494 lines
No EOL
195 KiB
HTML
494 lines
No EOL
195 KiB
HTML
<?xml version="1.0" encoding="utf-8"?>
|
||
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
|
||
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
|
||
|
||
<head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
|
||
<!-- AppResources meta begin -->
|
||
<meta name="paf-app-resources" content="" />
|
||
<script type="text/javascript">var ncbi_startTime = new Date();</script>
|
||
|
||
<!-- AppResources meta end -->
|
||
|
||
<!-- TemplateResources meta begin -->
|
||
<meta name="paf_template" content="" />
|
||
|
||
<!-- TemplateResources meta end -->
|
||
|
||
<!-- Logger begin -->
|
||
<meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK65453" /><meta name="ncbi_domain" content="nicecg14" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK65453/" /><meta name="ncbi_pagename" content="12. References - Clinical Guidelines for the Classification and Care of Women at Risk of Familial Breast Cancer in Primary, Secondary and Tertiary Care - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="ref-list" /><meta name="ncbi_app" content="bookshelf" />
|
||
<!-- Logger end -->
|
||
|
||
<title>12. References - Clinical Guidelines for the Classification and Care of Women at Risk of Familial Breast Cancer in Primary, Secondary and Tertiary Care - NCBI Bookshelf</title>
|
||
|
||
<!-- AppResources external_resources begin -->
|
||
<link rel="stylesheet" href="/core/jig/1.15.2/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.15.2/js/jig.min.js"></script>
|
||
|
||
<!-- AppResources external_resources end -->
|
||
|
||
<!-- Page meta begin -->
|
||
<meta name="robots" content="NOINDEX,NOFOLLOW,NOARCHIVE,NOIMAGEINDEX" /><meta name="citation_inbook_title" content="Clinical Guidelines for the Classification and Care of Women at Risk of Familial Breast Cancer in Primary, Secondary and Tertiary Care [Internet]" /><meta name="citation_title" content="12. References" /><meta name="citation_publisher" content="University of Sheffield" /><meta name="citation_date" content="2004/05" /><meta name="citation_author" content="School of Health and Related Research (ScHARR), University of Sheffield" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK65453/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="12. References" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Sheffield" /><meta name="DC.Contributor" content="School of Health and Related Research (ScHARR), University of Sheffield" /><meta name="DC.Date" content="2004/05" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK65453/" /><meta name="DC.Language" content="en" /><meta name="og:title" content="12. References" /><meta name="og:type" content="book" /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK65453/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-nicecg14-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="warning" content="This publication is provided for historical reference only and the information may be out of date." /><meta name="bk-non-canon-loc" content="/books/n/nicecg14/references.rl1/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK65453/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">.main-content {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/css/bookshelf/2.26/img/archive.png);background-size: auto, contain; padding:0 0 0 3em }</style><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace} .first-line-outdent .bk_ref {display: inline} .body-content h2, .body-content .h2 {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list .graphic {display:inline-block !important} .temp-labeled-list img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js?_=3.18"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.26/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.26/books.min.js"> </script><meta name="book-collection" content="nicecollect" />
|
||
|
||
<!-- Page meta end -->
|
||
<link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8B90A87D7A2E910000000000030003.m_13" />
|
||
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4216701/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/4207974/4206132/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/css/3411343/3882866.css" media="print" /></head>
|
||
<body class="book-part">
|
||
<div class="grid">
|
||
<div class="col twelve_col nomargin shadow">
|
||
<!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
|
||
<div class="sysmessages">
|
||
<noscript>
|
||
<p class="nojs">
|
||
<strong>Warning:</strong>
|
||
The NCBI web site requires JavaScript to function.
|
||
<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
|
||
</p>
|
||
</noscript>
|
||
</div>
|
||
<!--/.sysmessage-->
|
||
<div class="wrap">
|
||
<div class="page">
|
||
<div class="top">
|
||
<div id="universal_header">
|
||
<section class="usa-banner">
|
||
<div class="usa-accordion">
|
||
<header class="usa-banner-header">
|
||
<div class="usa-grid usa-banner-inner">
|
||
<img src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png" alt="U.S. flag" />
|
||
<p>An official website of the United States government</p>
|
||
<button class="non-usa-accordion-button usa-banner-button" aria-expanded="false" aria-controls="gov-banner-top" type="button">
|
||
<span class="usa-banner-button-text">Here's how you know</span>
|
||
</button>
|
||
</div>
|
||
</header>
|
||
<div class="usa-banner-content usa-grid usa-accordion-content" id="gov-banner-top" aria-hidden="true">
|
||
<div class="usa-banner-guidance-gov usa-width-one-half">
|
||
<img class="usa-banner-icon usa-media_block-img" src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg" alt="Dot gov" />
|
||
<div class="usa-media_block-body">
|
||
<p>
|
||
<strong>The .gov means it's official.</strong>
|
||
<br />
|
||
Federal government websites often end in .gov or .mil. Before
|
||
sharing sensitive information, make sure you're on a federal
|
||
government site.
|
||
</p>
|
||
</div>
|
||
</div>
|
||
<div class="usa-banner-guidance-ssl usa-width-one-half">
|
||
<img class="usa-banner-icon usa-media_block-img" src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg" alt="Https" />
|
||
<div class="usa-media_block-body">
|
||
<p>
|
||
<strong>The site is secure.</strong>
|
||
<br />
|
||
The <strong>https://</strong> ensures that you are connecting to the
|
||
official website and that any information you provide is encrypted
|
||
and transmitted securely.
|
||
</p>
|
||
</div>
|
||
</div>
|
||
</div>
|
||
</div>
|
||
</section>
|
||
<div class="usa-overlay"></div>
|
||
<header class="ncbi-header" role="banner" data-section="Header">
|
||
|
||
<div class="usa-grid">
|
||
<div class="usa-width-one-whole">
|
||
|
||
<div class="ncbi-header__logo">
|
||
<a href="/" class="logo" aria-label="NCBI Logo" data-ga-action="click_image" data-ga-label="NIH NLM Logo">
|
||
<img src="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg" alt="NIH NLM Logo" />
|
||
</a>
|
||
</div>
|
||
|
||
<div class="ncbi-header__account">
|
||
<a id="account_login" href="https://account.ncbi.nlm.nih.gov" class="usa-button header-button" style="display:none" data-ga-action="open_menu" data-ga-label="account_menu">Log in</a>
|
||
<button id="account_info" class="header-button" style="display:none" aria-controls="account_popup" type="button">
|
||
<span class="fa fa-user" aria-hidden="true">
|
||
<svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24" width="20px" height="20px">
|
||
<g style="fill: #fff">
|
||
<ellipse cx="12" cy="8" rx="5" ry="6"></ellipse>
|
||
<path d="M21.8,19.1c-0.9-1.8-2.6-3.3-4.8-4.2c-0.6-0.2-1.3-0.2-1.8,0.1c-1,0.6-2,0.9-3.2,0.9s-2.2-0.3-3.2-0.9 C8.3,14.8,7.6,14.7,7,15c-2.2,0.9-3.9,2.4-4.8,4.2C1.5,20.5,2.6,22,4.1,22h15.8C21.4,22,22.5,20.5,21.8,19.1z"></path>
|
||
</g>
|
||
</svg>
|
||
</span>
|
||
<span class="username desktop-only" aria-hidden="true" id="uname_short"></span>
|
||
<span class="sr-only">Show account info</span>
|
||
</button>
|
||
</div>
|
||
|
||
<div class="ncbi-popup-anchor">
|
||
<div class="ncbi-popup account-popup" id="account_popup" aria-hidden="true">
|
||
<div class="ncbi-popup-head">
|
||
<button class="ncbi-close-button" data-ga-action="close_menu" data-ga-label="account_menu" type="button">
|
||
<span class="fa fa-times">
|
||
<svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" width="24px" height="24px">
|
||
<path d="M38 12.83l-2.83-2.83-11.17 11.17-11.17-11.17-2.83 2.83 11.17 11.17-11.17 11.17 2.83 2.83 11.17-11.17 11.17 11.17 2.83-2.83-11.17-11.17z"></path>
|
||
</svg>
|
||
</span>
|
||
<span class="usa-sr-only">Close</span></button>
|
||
<h4>Account</h4>
|
||
</div>
|
||
<div class="account-user-info">
|
||
Logged in as:<br />
|
||
<b><span class="username" id="uname_long">username</span></b>
|
||
</div>
|
||
<div class="account-links">
|
||
<ul class="usa-unstyled-list">
|
||
<li><a id="account_myncbi" href="/myncbi/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_myncbi">Dashboard</a></li>
|
||
<li><a id="account_pubs" href="/myncbi/collections/bibliography/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_pubs">Publications</a></li>
|
||
<li><a id="account_settings" href="/account/settings/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_settings">Account settings</a></li>
|
||
<li><a id="account_logout" href="/account/signout/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_logout">Log out</a></li>
|
||
</ul>
|
||
</div>
|
||
</div>
|
||
</div>
|
||
|
||
</div>
|
||
</div>
|
||
</header>
|
||
<div role="navigation" aria-label="access keys">
|
||
<a id="nws_header_accesskey_0" href="https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys" class="usa-sr-only" accesskey="0" tabindex="-1">Access keys</a>
|
||
<a id="nws_header_accesskey_1" href="https://www.ncbi.nlm.nih.gov" class="usa-sr-only" accesskey="1" tabindex="-1">NCBI Homepage</a>
|
||
<a id="nws_header_accesskey_2" href="/myncbi/" class="set-base-url usa-sr-only" accesskey="2" tabindex="-1">MyNCBI Homepage</a>
|
||
<a id="nws_header_accesskey_3" href="#maincontent" class="usa-sr-only" accesskey="3" tabindex="-1">Main Content</a>
|
||
<a id="nws_header_accesskey_4" href="#" class="usa-sr-only" accesskey="4" tabindex="-1">Main Navigation</a>
|
||
</div>
|
||
<section data-section="Alerts">
|
||
<div class="ncbi-alerts-placeholder"></div>
|
||
</section>
|
||
</div>
|
||
<div class="header">
|
||
<div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
|
||
<div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" data-ac_dict="bookshelf-search">Books</option><option value="pubmed">PubMed</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore" class="last">Nucleotide</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="protfam">Protein Family Models</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
|
||
<a href="/books/browse/">Browse Titles</a>
|
||
</li><li>
|
||
<a href="/books/advanced/">Advanced</a>
|
||
</li><li class="help">
|
||
<a href="/books/NBK3833/">Help</a>
|
||
</li><li class="disclaimer">
|
||
<a target="_blank" data-ga-category="literature_resources" data-ga-action="link_click" data-ga-label="disclaimer_link" href="https://www.ncbi.nlm.nih.gov/books/about/disclaimer/">Disclaimer</a>
|
||
</li></ul></div>
|
||
</div>
|
||
|
||
|
||
|
||
<!--<component id="Page" label="headcontent"/>-->
|
||
|
||
</div>
|
||
<div class="content">
|
||
<!-- site messages -->
|
||
<!-- Custom content 1 -->
|
||
<div class="col1">
|
||
|
||
</div>
|
||
|
||
<div class="container">
|
||
<div id="maincontent" class="content eight_col col">
|
||
<!-- Custom content in the left column above book nav -->
|
||
<div class="col2">
|
||
|
||
</div>
|
||
|
||
<!-- Book content -->
|
||
|
||
|
||
<!-- Custom content between navigation and content -->
|
||
<div class="col3">
|
||
|
||
</div>
|
||
|
||
<div class="document">
|
||
<div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>School of Health and Related Research (ScHARR), University of Sheffield. Clinical Guidelines for the Classification and Care of Women at Risk of Familial Breast Cancer in Primary, Secondary and Tertiary Care [Internet]. Sheffield (UK): University of Sheffield; 2004 May. (NICE Clinical Guidelines, No. 14.)</p></div><div class="bk_msg_box bk_bttm_mrgn clearfix bk_noprnt"><div class="iconblock clearfix"><a class="img_link icnblk_img" title="Table of Contents Page" href="/books/n/nicecg164guid/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-nicecg164guid-lrg.png" alt="Cover" height="100px" width="80px" /></a><div class="icnblk_cntnt"><ul class="messages"><li class="info icon"><span class="icon"><a href="/books/n/nicecg164guid/">A new version of this title is available</a></span></li></ul></div></div></div><div class="messagearea bk_noprnt" style="margin-bottom:1.3846em "><ul class="messages"><li class="warn icon"><span class="icon">This publication is provided for historical reference only and the information may be out of date.</span></li></ul></div><div class="bk_prnt"><p style="color:red;"><strong>This publication is provided for historical reference only and the information may be out of date.</strong></p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="Table of Contents Page" href="/books/n/nicecg14/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-nicecg14-lrg.png" alt="Cover of Clinical Guidelines for the Classification and Care of Women at Risk of Familial Breast Cancer in Primary, Secondary and Tertiary Care" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>Clinical Guidelines for the Classification and Care of Women at Risk of Familial Breast Cancer in Primary, Secondary and Tertiary Care [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK65453_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK65453_dtls__"><div>NICE Clinical Guidelines, No. 14.</div><div>School of Health and Related Research (ScHARR), University of Sheffield.</div><div>Sheffield (UK): <a href="https://www.sheffield.ac.uk/scharr" ref="pagearea=page-banner&targetsite=external&targetcat=link&targettype=publisher">University of Sheffield</a>; 2004 May.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/nicecg14/">Contents</a></li></ul></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/nicecg14/glossary.gl1/" title="Previous page in this title">< Prev</a><a class="active page_link next" href="/books/n/nicecg14/appendixes.appgroup1/" title="Next page in this title">Next ></a></div></div></div></div></div>
|
||
<div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK65453_"><span class="title" itemprop="name">12. References</span></h1></div><div class="body-content whole_rhythm" itemprop="text"><ul class="first-line-outdent"><li><div class="bk_ref" id="references.r1">Aitken LS, West SG, Woodward CK, et al. Increasing screening mammography in asymptomatic women: evaluation of a second generation theory-based program. <span><span class="ref-journal">Health Psychology. </span>1994;<span class="ref-vol">13</span>:122–29.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/7889908" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 7889908</span></a>]</div></li><li><div class="bk_ref" id="references.r2">Amir E, Evans DG, Shenton A, Lalloo F, Moran A, Boggis C, Wilson M, Howell A. Evaluation of Breast Cancer Risk Assessment Packages in the Family History Evaluation and Screening Programme. <span><span class="ref-journal">J Med Genet. </span>2003</span> in press. [<a href="/pmc/articles/PMC1735317/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC1735317</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14627668" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 14627668</span></a>]</div></li><li><div class="bk_ref" id="references.r3">Andermann AA, Austoker J, Watson EK, et al. Development and evaluation of a general information leaflet for women with a family history of breast cancer. <span><span class="ref-journal">Journal of Cancer Education. </span>2002;<span class="ref-vol">17</span>:155–60.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12243221" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 12243221</span></a>]</div></li><li><div class="bk_ref" id="references.r4">Andermann A, Narod SA. Genetic counselling for familial breast and ovarian cancer in Ontario. <span><span class="ref-journal">Journal of Medical Genetics. </span>2002;<span class="ref-vol">39</span>:695–696.</span> [<a href="/pmc/articles/PMC1735233/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC1735233</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12205116" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 12205116</span></a>]</div></li><li><div class="bk_ref" id="references.r5">Andermann AA, Watson EK, Lucassen AM, Austoker J. The Opinions, Expectations and Experiences of Women with a Family History of Breast Cancer Who Consult Their GP and Are Referred to Secondary Care. <span><span class="ref-journal">Community Genet. </span>2001;<span class="ref-vol">4</span>(4):239–43.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12107353" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 12107353</span></a>]</div></li><li><div class="bk_ref" id="references.r6">Anderson DE, et al. Risk of familial breast cancer. <span><span class="ref-journal">Cancer. </span>1985;<span class="ref-vol">56</span>:937–48.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/4005803" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 4005803</span></a>]</div></li><li><div class="bk_ref" id="references.r7">Antoniou A, Pharoah PDP, Narod S, et al. Average risks of breast and ovarian cancer associated with mutations in <em>BRCA1</em> or <em>BRCA2</em> detected in case series unselected for family history: a combined analysis of 22 studies. <span><span class="ref-journal">Am J Hum Genet. </span>2003;<span class="ref-vol">72</span>(5):1117–30.</span> [<a href="/pmc/articles/PMC1180265/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC1180265</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12677558" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 12677558</span></a>]</div></li><li><div class="bk_ref" id="references.r8">Arnold N, et al. A highly sensitive, fast, and economical technique for mutation analysis in hereditary breast and ovarian cancers. <span><span class="ref-journal">Hum Mutat. </span>1999;<span class="ref-vol">14</span>:333–9.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10502781" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10502781</span></a>]</div></li><li><div class="bk_ref" id="references.r9">Band PR, et al. Carcinogenic and endocrine disrupting effects of cigarette smoke and risk of breast cancer. <span><span class="ref-journal">Lancet. </span>2002;<span class="ref-vol">360</span>:1044–1049.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12383984" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 12383984</span></a>]</div></li><li><div class="bk_ref" id="references.r10">Bastani R, Maxwell A, Bradford C, et al. Tailored risk notification for women with a family history of breast cancer. <span><span class="ref-journal">Preventive Medicine. </span>1999;<span class="ref-vol">29</span>:355–364.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10564627" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10564627</span></a>]</div></li><li><div class="bk_ref" id="references.r11">Baxter N, et al. Preventative Health Care, 2001 Update: Should Women Be Routinely Taught Breast Self-Examination to Screen for Breast Cancer. <span><span class="ref-journal">CMAJ. </span>2001;<span class="ref-vol">164</span>(13)</span> [<a href="/pmc/articles/PMC81191/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC81191</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11450279" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11450279</span></a>]</div></li><li><div class="bk_ref" id="references.r12">Bebbington Hatcher M, Fallowfield L. A qualitative study looking at the psychosocial implications of bilateral prophylactic mastectomy. <span><span class="ref-journal">The Breast. </span>2003;<span class="ref-vol">12</span>:1–9.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/14659349" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 14659349</span></a>]</div></li><li><div class="bk_ref" id="references.r13">Bernhardt B, et al. Toward a model informed consent process for BRCA1 testing: a qualitative assessment of women’s attitudes. <span><span class="ref-journal">Journal of Genetic Counseling. </span>1997;<span class="ref-vol">6</span>:207–22.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11656642" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11656642</span></a>]</div></li><li><div class="bk_ref" id="references.r14">Bernier MO, et al. Breastfeeding and risk of breast cancer: a meta-analysis of published studies. <span><span class="ref-journal">Human Reproduction Update. </span>2000;<span class="ref-vol">6</span>:374–86.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10972524" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10972524</span></a>]</div></li><li><div class="bk_ref" id="references.r15">Berry DA, Parmigiani G, Sanchez J, Schildkraut J, Winer E. Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history. <span><span class="ref-journal">Journal of the National Cancer Institute. </span>1997;<span class="ref-vol">89</span>:227–38.</span> (see comments) [<a href="https://pubmed.ncbi.nlm.nih.gov/9017003" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 9017003</span></a>]</div></li><li><div class="bk_ref" id="references.r16">Berry DA, Parmigiani G, Sanchez J, Schildkraut J, Winer E. Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history. <span><span class="ref-journal">Journal of the National Cancer Institute. </span>1997;<span class="ref-vol">89</span>:227–38.</span> (see comments) [<a href="https://pubmed.ncbi.nlm.nih.gov/9017003" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 9017003</span></a>]</div></li><li><div class="bk_ref" id="references.r17">Bondy ML, Lustbader ED, Halabi S, Ross E, Vogel VG. Validation of a breast cancer risk assessment model in women with a positive family history. <span><span class="ref-journal">Journal of the National Cancer Institute. </span>1994;<span class="ref-vol">86</span>:620–5.</span> (see comments) [<a href="https://pubmed.ncbi.nlm.nih.gov/8003106" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 8003106</span></a>]</div></li><li><div class="bk_ref" id="references.r18">Borgen PI, Hill ADK, Tran KN, Van Zee KJ, Massie MJ, Payne D, et al. Patient regrets after bilateral prophylactic mastectomy. <span><span class="ref-journal">Annals of Surgical Oncology. </span>1998;<span class="ref-vol">5</span>:603–6.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9831108" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 9831108</span></a>]</div></li><li><div class="bk_ref" id="references.r19">Bottorff JL, Balneaves LG, Buxton J, Ratner PA, McCullum M, Chalmers K, et al. Falling through the cracks. Women’s experiences of ineligibility for genetic testing for risk of breast cancer. <span><span class="ref-journal">Canadian Family Physician. </span>2000;<span class="ref-vol">46</span>:1449–56.</span> [<a href="/pmc/articles/PMC2144854/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC2144854</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10925759" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10925759</span></a>]</div></li><li><div class="bk_ref" id="references.r20">Bottorff JL, et al. Communicating cancer risk information: the challenges of uncertainty. <span><span class="ref-journal">Patient Educ Couns. </span>1998;<span class="ref-vol">33</span>:67–81.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9481350" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 9481350</span></a>]</div></li><li><div class="bk_ref" id="references.r21">Bowles Biesecker B, Ishibe N, Hadley DW, Giambarresi TR, Kase RG, Lerman C, et al. Psychosocial Factors Predicting BRCA1/BRCA2 Testing Decisions in Members of Hereditary Breast and Ovarian Families. <span><span class="ref-journal">Am J Med Genet. </span>2000;<span class="ref-vol">93</span>:257–63.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10946349" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10946349</span></a>]</div></li><li><div class="bk_ref" id="references.r22">Boyd NF, Lockwood GA, Martin LJ, Knight JA, Jong RA, Fishell E, et al. Mammographic densities and risk of breast cancer among subjects with a family history of this disease. <span><span class="ref-journal">Journal of the National Cancer Institute. </span>1999;<span class="ref-vol">91</span>:1404–8.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10451446" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10451446</span></a>]</div></li><li><div class="bk_ref" id="references.r23">Brain K, Gray J, Norman P, Parsons E, Clarke A, Rogers C, Mansel R, Harper P. Why do women attend familial beast cancer clinics? <span><span class="ref-journal">Journal of Medical Genetics. </span>1999;<span class="ref-vol">37</span>:197–202.</span> [<a href="/pmc/articles/PMC1734549/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC1734549</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10699056" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10699056</span></a>]</div></li><li><div class="bk_ref" id="references.r24">Brekelmans CT, Seynaeve C, Bartels CC, Tilanus-Linthorst MM, Meijers-Heijboer EJ, Crepin CM, et al. Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk. <span><span class="ref-journal">Journal of Clinical Oncology. </span>2001;<span class="ref-vol">19</span>:924–30.</span> (see comments) [<a href="https://pubmed.ncbi.nlm.nih.gov/11181654" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11181654</span></a>]</div></li><li><div class="bk_ref" id="references.r25">Brind J, et al. Induced abortion as an independent risk factor for breast cancer: a comprehensive review and meta-analysis. <span><span class="ref-journal">Journal of Epidemiology & Community Health. </span>1996;<span class="ref-vol">50</span>:481–96.</span> [<a href="/pmc/articles/PMC1060338/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC1060338</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8944853" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 8944853</span></a>]</div></li><li><div class="bk_ref" id="references.r26">Broadstock M, Michie S, Gray J, Mackay J, Marteau TM. The psychological consequences of offering mutation searching in the family for those at risk of hereditary breast and ovarian cancer--a pilot study. <span><span class="ref-journal">Psycho-Oncology. </span>2000;<span class="ref-vol">9</span>:537–48.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11180589" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11180589</span></a>]</div></li><li><div class="bk_ref" id="references.r27">Bush TL, Whiteman M, Flaws JA. Hormone replacement therapy and breast cancer: A qualitative review. <span><span class="ref-journal">Obstetrics-and-Gynecology. </span>2001;<span class="ref-vol">98</span>:498–508.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11530137" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11530137</span></a>]</div></li><li><div class="bk_ref" id="references.r28">Butow PN, Lobb EA, Meiser B, Barratt A, Tucker KM. Psychological outcomes and risk perception after genetic testing and counselling in breast cancer: a systematic review. <span><span class="ref-journal">Medical Journal of Australia. </span>2003;<span class="ref-vol">178</span>:77–81.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12526728" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 12526728</span></a>]</div></li><li><div class="bk_ref" id="references.r29">Byrne TJ, Reece MT, Adams LA, Hoffman DE, Lane MA, Cohn GM. A rapid immunoassay predicts BRCA 1 and BRCA 2 mutations in buccal cells. <span><span class="ref-journal">Oncol rep. </span>2000;<span class="ref-vol">7</span>:1203–7.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11032914" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11032914</span></a>]</div></li><li><div class="bk_ref" id="references.r30">Cameron LD, Diefenbach MA. Responses to information about psychosocial consequences of genetic testing from breast cancer susceptibility: influences of cancer worry and risk perceptions. <span><span class="ref-journal">Journal of Health Psychology. </span>2001;<span class="ref-vol">6</span>:47–59.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22049237" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 22049237</span></a>]</div></li><li><div class="bk_ref" id="references.r31">Cappelli M, et al. Psychological and social predictors of decisions about genetic testing for breast cancer in high-risk women. <span><span class="ref-journal">Psychology, Health & Medicine. </span>2001;<span class="ref-vol">6</span>:321–33.</span></div></li><li><div class="bk_ref" id="references.r32">Casilli F, Di Rocco ZC, Gad S, Tournier I, Stoppa-Lyonnet D, Frebourg T, et al. Rapid detection of novel BRCA 1 rearrangements in high-risk n=breast-ovarian cancer families using multiplex PCR of short flourescent lights. <span><span class="ref-journal">Hum Mutat. </span>2002;<span class="ref-vol">20</span>:218–26.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12203994" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 12203994</span></a>]</div></li><li><div class="bk_ref" id="references.r33">Chalmers K, Thomson K. Coming to terms with the risk of breast cancer: Perceptions of women with primary relatives with breast cancer. <span><span class="ref-journal">Qualitative Health Research. </span>1996;<span class="ref-vol">6</span>:256–282.</span></div></li><li><div class="bk_ref" id="references.r34">Chart PL, Franssen E. Management of women at increased risk for breast cancer: preliminary results from a new program. <span><span class="ref-journal">CMAJ. </span>1997;<span class="ref-vol">157</span>:1235–42.</span> [<a href="/pmc/articles/PMC1228353/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC1228353</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9361645" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 9361645</span></a>]</div></li><li><div class="bk_ref" id="references.r35">Claus EB, Risch N, Thompson WD. Autosomal dominant inheritance of early onset breast cancer. <span><span class="ref-journal">Cancer. </span>1994;<span class="ref-vol">73</span>:643–651.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/8299086" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 8299086</span></a>]</div></li><li><div class="bk_ref" id="references.r36">Cohen D, Barton G, Gray J. The cost of mutation searching on BRCA1 and BRCA2 for breast cancer predisposition. <span></span> in submission.</div></li><li><div class="bk_ref" id="references.r37">Colditz GA, Egan KM, Stampfer MJ. Hormone replacement therapy and risk of breast cancer: results from epidemiologic studies. <span><span class="ref-journal">American Journal of Obstetrics & Gynecology. </span>1993;<span class="ref-vol">168</span>:1473–80.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/8498430" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 8498430</span></a>]</div></li><li><div class="bk_ref" id="references.r38">
|
||
Collaborative Group on Hormonal Factors in Breast Cancer. Alcohol, tobacco and breast cancer – collaborative reanalysis of individual data from 53 epidemiological studies, including 58 515 women with breast cancer and 95 067 women without the disease. <span><span class="ref-journal">Lancet. </span>2002;<span class="ref-vol">87</span>:1234–45.</span> [<a href="/pmc/articles/PMC2562507/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC2562507</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12439712" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 12439712</span></a>]</div></li><li><div class="bk_ref" id="references.r39">
|
||
Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50,302 women with breast cancer and 96, 973 women without the disease. <span><span class="ref-journal">Lancet. </span>2002;<span class="ref-vol">360</span>:187–95.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12133652" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 12133652</span></a>]</div></li><li><div class="bk_ref" id="references.r40">
|
||
Collaborative Group on Hormonal Factors in Breast Cancer. Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58 209 women with breast cancer and 101 986 women without the disease. <span><span class="ref-journal">Lancet. </span>2001;<span class="ref-vol">358</span>:1389–1399.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11705483" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11705483</span></a>]</div></li><li><div class="bk_ref" id="references.r41">
|
||
Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52, 705 women with breast cancer and 108, 411 women without breast cancer. <span><span class="ref-journal">Lancet. </span>1997;<span class="ref-vol">350</span>:1047–59.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10213546" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10213546</span></a>]</div></li><li><div class="bk_ref" id="references.r42">
|
||
Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. <span><span class="ref-journal">Lancet. </span>1996;<span class="ref-vol">347</span>:1713–27.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/8656904" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 8656904</span></a>]</div></li><li><div class="bk_ref" id="references.r43">Contant C, et al. Clinical experience of prophylactic mastectomy followed by immediate breast reconstruction in women at hereditary risk of breast cancer (HB(O)C) or a proven BRCA1 and BRCA2 germ-line mutation. <span><span class="ref-journal">European Journal of Surgical Oncology. </span>2002;<span class="ref-vol">28</span>:627–32.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12359199" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 12359199</span></a>]</div></li><li><div class="bk_ref" id="references.r44">Couch FJ, et al. Cigarette smoking increases risk for breast cancer in high-risk breast cancer families. <span><span class="ref-journal">Cancer Epidemiology, Biomarkers & Prevention. </span>2001;<span class="ref-vol">10</span>:327–32.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11319172" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11319172</span></a>]</div></li><li><div class="bk_ref" id="references.r45">Croyle RT, Smith KR, Botkin JR, Baty B, Nash J. Psychological responses to BRCA1 mutation testing: preliminary findings. <span><span class="ref-journal">Health Psychology. </span>1997;<span class="ref-vol">16</span>:63–72.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9028816" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 9028816</span></a>]</div></li><li><div class="bk_ref" id="references.r46">Cull A, Anderson E, D C, Campbell S, Mackay J, Smyth E, Steel M. The impact of genetic counselling about breast cancer risk on women’s risk perceptions and levels of distress. <span><span class="ref-journal">British Journal of Cancer. </span>1999;<span class="ref-vol">79</span>:501–508.</span> [<a href="/pmc/articles/PMC2362435/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC2362435</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10027320" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10027320</span></a>]</div></li><li><div class="bk_ref" id="references.r47">Cull A, Miller H, Porterfield T, Mackay J, Anderson E, D C, Steel CM, Elton RA. The use of videotaped information in cancer genetic counselling: a randomized evaluation study. <span><span class="ref-journal">British Journal of Cancer. </span>1998;<span class="ref-vol">77</span>:830–837.</span> [<a href="/pmc/articles/PMC2149970/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC2149970</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9514066" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 9514066</span></a>]</div></li><li><div class="bk_ref" id="references.r48">Curry SJ, Taplin SH, Anderman C, et al. A randomized trial of the impact of risk assessment and feedback on participation in mammography screening. <span><span class="ref-journal">Preventive Medicine. </span>1993;<span class="ref-vol">22</span>:350–60.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/8327418" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 8327418</span></a>]</div></li><li><div class="bk_ref" id="references.r49">Cuzick J, Powles T, Veronesi U, Forbes J, Edwards R, Ashley S, Boyle P. Overview of the main outcomes in breast-cancer prevention trials. <span><span class="ref-journal">Lancet. </span>2003;<span class="ref-vol">361</span>:296–300.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12559863" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 12559863</span></a>]</div></li><li><div class="bk_ref" id="references.r50">Day R, Ganz PA, Constantino JP, et al. Health related quality of life and tamoxifen in breast cancer prevention: a report from the National Surgical Adjuvant Breast and Bowel Project (P-1 Project). <span><span class="ref-journal">Journal of Clinical Oncology. </span>1999;<span class="ref-vol">17</span>:2659–2669.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10561339" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10561339</span></a>]</div></li><li><div class="bk_ref" id="references.r51">de Bock GH, Vliet Vlieland TP, Hageman GC, Oosterwijk JC, Springer MP, Kievit J. The assessment of genetic risk of breast cancer: a set of GP guidelines. <span><span class="ref-journal">Family Practice. </span>1999;<span class="ref-vol">16</span>:71–7.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10321400" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10321400</span></a>]</div></li><li><div class="bk_ref" id="references.r52">Delgado-Rodriguez M, et al. Oral contraceptives and breast cancer: a meta-analysis. <span><span class="ref-journal">Revue d'Epidemiologie et de Sante Publique. </span>1991;<span class="ref-vol">39</span>:165–81.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/1830968" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 1830968</span></a>]</div></li><li><div class="bk_ref" id="references.r53">Department of Health. <span class="ref-journal">Interim advice to GPs on familial breast cancer.</span> London: Department of Health; 2000. </div></li><li><div class="bk_ref" id="references.r54">Diefenbach MA, et al. Specific worry about breast cancer predicts mammography use in women at risk for breast and ovarian cancer. <span><span class="ref-journal">Health Psychology. </span>1999;<span class="ref-vol">18</span>:532–6.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10519469" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10519469</span></a>]</div></li><li><div class="bk_ref" id="references.r55">Douglas FS, O'Dair LCO, Robinson M, Evans DGR, Lynch SA. The accuracy of diagnosis as reported by the proband in families with cancer: a retrospective study. <span><span class="ref-journal">J Med Genet. </span>1999;<span class="ref-vol">36</span>:309–12.</span> 1999. [<a href="/pmc/articles/PMC1734350/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC1734350</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10227399" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10227399</span></a>]</div></li><li><div class="bk_ref" id="references.r56">Doyle P, Maconochie N, Beral V, et al. Cancer incidence following treatment for infertility at a clinic in the UK. <span><span class="ref-journal">Human Reproduction. </span>2002;<span class="ref-vol">17</span>:2209–2213.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12151460" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 12151460</span></a>]</div></li><li><div class="bk_ref" id="references.r57">Drossaert CCH. Perceived risk, anxiety, mammogram uptake, and breast self-examination of women with a family history of breast cancer: the role of knowing to be at increased risk. <span><span class="ref-journal">Cancer Detection & Prevention. </span>1996;<span class="ref-vol">20</span>:76–85.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/8907207" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 8907207</span></a>]</div></li><li><div class="bk_ref" id="references.r58">Dupont WD, Page DL. Menopausal estrogen replacement therapy and breast cancer. <span><span class="ref-journal">Archives of Internal Medicine. </span>1991;<span class="ref-vol">151</span>:167–72.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/1824675" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 1824675</span></a>]</div></li><li><div class="bk_ref" id="references.r59">Durfy SJ, Bowen DJ, McTiernan A, Sporleder J, Burke W. Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in western Washington. <span><span class="ref-journal">Cancer Epidemiology, Biomarkers & Prevention. </span>1999;<span class="ref-vol">8</span>:369–75.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10207642" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10207642</span></a>]</div></li><li><div class="bk_ref" id="references.r60">Eccles DM, Evans DG, Mackay J. Guidelines for a genetic risk based approach to advising women with a family history of breast cancer. UK Cancer Family Study Group (UKCFSG). <span><span class="ref-journal">Journal of Medical Genetics. </span>2000;<span class="ref-vol">37</span>:203–9.</span> [<a href="/pmc/articles/PMC1734545/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC1734545</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10699057" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10699057</span></a>]</div></li><li><div class="bk_ref" id="references.r61">Edwards SM, Kote-Jarai Z, Meitz J, et al.
|
||
Cancer Research UK/Bristish Prostate Group UK Familial Prostate Cancer Study Collaborators; British Association of Urological Surgeons Section of Oncology. Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene. <span><span class="ref-journal">Am J Hum Genet. </span>2002;<span class="ref-vol">72</span>:1–12.</span> Epub 2002 Dec 09. [<a href="/pmc/articles/PMC420008/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC420008</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12474142" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 12474142</span></a>]</div></li><li><div class="bk_ref" id="references.r62">Edwards SM, Kote-Jarai Z, Hamoudi R, Eeles RA. An improved high throughput heteroduplex mutation detection system for screening BRCA2 mutations-flourescent mutation detection (F-MD). <span><span class="ref-journal">Hum Mutat. </span>2001;<span class="ref-vol">17</span>:220–32.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11241844" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11241844</span></a>]</div></li><li><div class="bk_ref" id="references.r63">Eeles RA, Murday VA. The cancer family clinic. In: Eeles RA, et al., editors. <span class="ref-journal">Genetic Predisposition to Cancer.</span> Oxford: Chapman & Hall Medical; 1996. </div></li><li><div class="bk_ref" id="references.r64">Eerola H, Blomqvist C, Pukkala E, Pyrhonen S, Nevanlinna H. Familial breast cancer in southern Finland: how prevalent are breast cancer families and can we trust the family history reported by patients? <span><span class="ref-journal">European Journal of Cancer. </span>2000;<span class="ref-vol">36</span>:1143–8.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10854948" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10854948</span></a>]</div></li><li><div class="bk_ref" id="references.r65">Eldar S, Meguid MM, Beatty JD. Cancer of the Breast After Prophylactic Subcutaneous Mastectomy. <span><span class="ref-journal">American Journal of Surgery. </span>1984;<span class="ref-vol">148</span>:692–3.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/6496863" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 6496863</span></a>]</div></li><li><div class="bk_ref" id="references.r66">Elit L, Esplen MJ, Butler K, Narod S. Quality of life and psychosexual adjustment after prophylactic oophorectomy for a family history of ovarian cancer. <span><span class="ref-journal">Familial Cancer. </span>2001;<span class="ref-vol">1</span>:149–56.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/14574171" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 14574171</span></a>]</div></li><li><div class="bk_ref" id="references.r67">Elit L, Rosen B, Gael V, Michaughlin J, Fung MKF, Shime J, Narod S. Prophylactic oophorectomy in Ontario. <span><span class="ref-journal">Familial Cancer. </span>2001;<span class="ref-vol">1</span>:143–8.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/14574170" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 14574170</span></a>]</div></li><li><div class="bk_ref" id="references.r68">Ellison RC, et al. Exploring the relation of alcohol consumption to risk of breast cancer. <span><span class="ref-journal">American Journal of Epidemiology. </span>2001;<span class="ref-vol">154</span>:740–7.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11590087" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11590087</span></a>]</div></li><li><div class="bk_ref" id="references.r69">Emery J, Lucassen A, Murphy M. Common hereditary cancers and implications for primary care. <span><span class="ref-journal">Lancet. </span>2001;<span class="ref-vol">358</span>:56–63.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11454400" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11454400</span></a>]</div></li><li><div class="bk_ref" id="references.r70">Emery J, Walton R, Coulson A, Glasspool D, Ziebland S, Fox J. Computer support for recording and interpreting family histories of breast and ovarian cancer in primary care (RAGs): qualitative evaluation with simulated patients. <span><span class="ref-journal">BMJ. </span>1999;<span class="ref-vol">319</span>:32–6.</span> [<a href="/pmc/articles/PMC28153/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC28153</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10390458" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10390458</span></a>]</div></li><li><div class="bk_ref" id="references.r71">Emery J, Walton R, Murphy M, Austoker J, Yudkin P, Chapman C, et al. Computer support for interpreting family histories of breast and ovarian cancer in primary care: comparative study with simulated cases. <span><span class="ref-journal">BMJ. </span>2000;<span class="ref-vol">321</span>:28–32.</span> (see comments) [<a href="/pmc/articles/PMC27423/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC27423</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10875832" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10875832</span></a>]</div></li><li><div class="bk_ref" id="references.r72">Euhus DM, Smith KC, Robinson L, et al. Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO. <span><span class="ref-journal">Journal of the National Cancer Institute. </span>2002;<span class="ref-vol">94</span>:844–51.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12048272" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 12048272</span></a>]</div></li><li><div class="bk_ref" id="references.r73">Evans DG, Blair V, Greenhalgh R, Hopwood P, Howell A. The impact of genetic counselling on risk perception in women with a family history of breast cancer. <span><span class="ref-journal">Br J Cancer. </span>1994;<span class="ref-vol">70</span>:934–938.</span> [<a href="/pmc/articles/PMC2033538/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC2033538</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7947100" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 7947100</span></a>]</div></li><li><div class="bk_ref" id="references.r74">Evans DG, Blair V, Greenhalgh R, Hopwood P, Howell A. The impact of genetic counselling on risk perception in women with a family history of breast cancer. <span><span class="ref-journal">British Journal of Cancer. </span>1994;<span class="ref-vol">70</span>:934–938.</span> [<a href="/pmc/articles/PMC2033538/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC2033538</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7947100" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 7947100</span></a>]</div></li><li><div class="bk_ref" id="references.r75">Evans DGR, Lalloo F, Shenton A, Boggis C, Howell A. Uptake of screening and prevention in women at very high risk of breast cancer. <span><span class="ref-journal">The Lancet. </span>2001;<span class="ref-vol">358</span>:889–90.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11567707" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11567707</span></a>]</div></li><li><div class="bk_ref" id="references.r76">Fallowfield L, Fleissig A, Edwards R, West A, Powles TJ, Howell A, et al. Tamoxifen for the prevention of breast cancer: psychosocial impact on women participating in two randomized controlled trials. <span><span class="ref-journal">Journal of Clinical Oncology. </span>2001;<span class="ref-vol">19</span>:1885–92.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11283119" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11283119</span></a>]</div></li><li><div class="bk_ref" id="references.r77">Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. <span><span class="ref-journal">Journal of the National Cancer Institute. </span>1998;<span class="ref-vol">90</span>:1371–88.</span> (see comments) 1998. [<a href="https://pubmed.ncbi.nlm.nih.gov/9747868" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 9747868</span></a>]</div></li><li><div class="bk_ref" id="references.r78">Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. <span><span class="ref-journal">Journal of the National Cancer Institute. </span>1998;<span class="ref-vol">90</span>:1371–88.</span> (see comments) 1998. [<a href="https://pubmed.ncbi.nlm.nih.gov/9747868" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 9747868</span></a>]</div></li><li><div class="bk_ref" id="references.r79">Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, et al. The Breast Cancer Linkage Consortium: Genetic Heterogeneity and Penetrance Analysis of the <em>BRCA1</em> and <em>BRCA2</em> genes in breast cancer families. <span><span class="ref-journal">Am J Hum Genet. </span>1998;<span class="ref-vol">62</span>:676–689.</span> [<a href="/pmc/articles/PMC1376944/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC1376944</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9497246" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 9497246</span></a>]</div></li><li><div class="bk_ref" id="references.r80">Foster C, Evans DGR, Eeles R, et al. Predictive testing for BRCA1/2: attributes, risk perception and management in a multi-centre clinical cohort. <span><span class="ref-journal">BR J CANCER. </span>2002;<span class="ref-vol">86</span>:1209–16.</span> [<a href="/pmc/articles/PMC2375339/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC2375339</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11953874" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11953874</span></a>]</div></li><li><div class="bk_ref" id="references.r81">Frolov A, Prowse AH, Vanderveer L, Bove B, Wu H, Godwin AK. DNA array-based method for detection of large rearrangements in the BRCA 1 gene. <span><span class="ref-journal">Genes Chromosomes Cancer. </span>2002;<span class="ref-vol">35</span>:232–41.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12353265" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 12353265</span></a>]</div></li><li><div class="bk_ref" id="references.r82">Frost MH, Schaid DJ, Sellers TA, Slezak JM, Arnold PG, Woods JE, et al. Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy. <span><span class="ref-journal">Jama-Journal of the American Medical Association. </span>2000;<span class="ref-vol">284</span>:319–24.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10891963" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10891963</span></a>]</div></li><li><div class="bk_ref" id="references.r83">Fry A, Busby-Earle C, Rush R, Cull A. Prophylactic oophorectomy versus screening: psychosocial outcomes in women at increased risk of ovarian cancer. <span><span class="ref-journal">Psycho-Oncology. </span>2001;<span class="ref-vol">10</span>:231–41.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11351375" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11351375</span></a>]</div></li><li><div class="bk_ref" id="references.r84">Gad S, Aurias A, Puget N, Mairal A, Schurra C, Montagna M, et al. Colour bar coding the BRcA 1 gene on combed DNA: a useful strategy for detecting large gene arrangements. <span><span class="ref-journal">Genes Chromosomes Cancer. </span>2001;<span class="ref-vol">31</span>:75–84.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11284038" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11284038</span></a>]</div></li><li><div class="bk_ref" id="references.r85">Gail MH, Brinton LA, Byar DP, Corle DK, Gree SB, Schairer C, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. <span><span class="ref-journal">Journal of the National Cancer Institute. </span>1989;<span class="ref-vol">81</span>:1879–86.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/2593165" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 2593165</span></a>]</div></li><li><div class="bk_ref" id="references.r86">Gail MH, Costantino JP, Bryant J, Croyle R, Freedman L, Helzlsouer K, Vogel V. Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer. <span><span class="ref-journal">Journal of the National Cancer Institute. </span>1999;<span class="ref-vol">91</span>:1829–46.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10547390" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10547390</span></a>]</div></li><li><div class="bk_ref" id="references.r87">Ganguly T, Dhulipala R, Godmilow L, Ganguly A. High throughput fluorescence-based conformation-sensitive gel electrophoresis (F-CSGE) identifies six unique BRCA2 mutations and an overall low incidence of BRCA2 mutations in high-risk BRCA1-negative breast cancer families. <span><span class="ref-journal">Human Genetics. </span>1998;<span class="ref-vol">102</span>:549–56.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9654203" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 9654203</span></a>]</div></li><li><div class="bk_ref" id="references.r88">Gayther SA, Harrington P, Russell PKG, Garkavtseva RF, Ponder BA. Rapid detection of regionally clustered germ-line BRCA 1 mutations by multiplex heteroduplex analysis. UKCCCR Familial Ovarian Cancer Study Group. <span><span class="ref-journal">Am J Hum Genet. </span>1996;<span class="ref-vol">58</span>:451–6.</span> [<a href="/pmc/articles/PMC1914578/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC1914578</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8644703" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 8644703</span></a>]</div></li><li><div class="bk_ref" id="references.r89">Geisler JP, Hatterman-Zogg MA, Rathe JA, Lallas TA, Kirby P, Buller RE. Ovarian cancer BRCA1 mutation detection: Protein truncation test (PTT) outperforms single strand confrontation polymorphism analysis (SSCP). <span><span class="ref-journal">Hum Mutat. </span>2001;<span class="ref-vol">18</span>:337–44.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11668617" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11668617</span></a>]</div></li><li><div class="bk_ref" id="references.r90">Gilbert FJ, Cordiner CM, Affleck IR, Hood DB, Mathieson D, Walker LG. Breast screening: the psychological sequelae of false-positive recall in women with and without a family history of breast cancer. <span><span class="ref-journal">European Journal of Cancer. </span>1998;<span class="ref-vol">34</span>:2010–4.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10070302" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10070302</span></a>]</div></li><li><div class="bk_ref" id="references.r91">Gilpin CA, Carson N, Hunter AG. A preliminary validation of a family history assessment form to select women at risk for breast or ovarian cancer for referral to a genetics center. <span><span class="ref-journal">Clinical Genetics. </span>2000;<span class="ref-vol">58</span>:299–308.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11076055" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11076055</span></a>]</div></li><li><div class="bk_ref" id="references.r92">Goffin J, Chappuis PO, Wong N, Foulkes WD, Stoutjesdijk MJ, Boetes C, et al. Re: Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer (2). <span><span class="ref-journal">Journal of the National Cancer Institute. </span>:1754–5.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11717339" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11717339</span></a>]</div></li><li><div class="bk_ref" id="references.r93">Goodnight JE, Quagliana JM, Morton DL. Failure of Subcutaneous Mastectomy to Prevent the Development of Breast-Cancer. <span><span class="ref-journal">Journal of Surgical Oncology. </span>1984;<span class="ref-vol">26</span>:198–201.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/6330460" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 6330460</span></a>]</div></li><li><div class="bk_ref" id="references.r94">Grande GE, Hyland F, Walter FM, Kinmonth AL. Women's views of consultations about familial risk of breast cancer in primary care. <span><span class="ref-journal">Patient Educ Couns. </span>2002;<span class="ref-vol">48</span>(3):275–82.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12477612" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 12477612</span></a>]</div></li><li><div class="bk_ref" id="references.r95">Grann VR, Jacobson JS, Thomason D, Hershman D, Heitjan DF, Neugut AI. Effect of prevention strategies on survival and quality adjusted survival of women with BRCA1/2 mutations: an updated decision analysis. <span><span class="ref-journal">Journal of Clinical Oncology. </span>2002;<span class="ref-vol">20</span>(10):2520–2529.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12011131" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 12011131</span></a>]</div></li><li><div class="bk_ref" id="references.r96">Grann, et al. Prevention with Tamoxifen or other hormones versus prophylactic surgery in BRCA1/2- positive women: a decision analysis. <span><span class="ref-journal">The Cancer Journal. </span>2000;<span class="ref-vol">6</span>:13–20.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10696733" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10696733</span></a>]</div></li><li><div class="bk_ref" id="references.r97">Grann, et al. Decision analysis of Tamoxifen for the prevention of invasive breast cancer. <span><span class="ref-journal">The Cancer Journal. </span>2000;<span class="ref-vol">6</span>:169–178.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10882333" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10882333</span></a>]</div></li><li><div class="bk_ref" id="references.r98">Grann, et al. Benefits and costs of screening Askenazi Jewish Women for BRCA1 and BRCA2. <span><span class="ref-journal">Journal of Clinical Oncology. </span>1999;<span class="ref-vol">17</span>(2):494–500.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10080590" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10080590</span></a>]</div></li><li><div class="bk_ref" id="references.r99">Grann VR, Panageas KS, Whang W, Antman KH, Neugut AI. Decision analysis of prophylactic mastectomy and oophorectomy in BRCA1-positive or BRCA2-positive patients. <span><span class="ref-journal">Journal of Clinical Oncology. </span>1998;<span class="ref-vol">16</span>:979–85.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9508180" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 9508180</span></a>]</div></li><li><div class="bk_ref" id="references.r100">Green J, et al. Family communication and genetic counseling: the case of hereditary breast and ovarian cancer. <span><span class="ref-journal">Journal of Genetic Counseling. </span>1997;<span class="ref-vol">6</span>:45–60.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26141962" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 26141962</span></a>]</div></li><li><div class="bk_ref" id="references.r101">Green MJ, Biesecker BB, McInerney AM, et al. An interactive computer program can effectively educate patients about genetic testing for breast cancer susceptibility. <span><span class="ref-journal">American Journal of Medical Genetics. </span>2001;<span class="ref-vol">103</span>:16–23.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11562929" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11562929</span></a>]</div></li><li><div class="bk_ref" id="references.r102">Green MJ, McInerney AM, Biesecker BB, Frost N. Education about genetic testing for breast cancer susceptibility: patient preferences for a computer program or genetic counsellor. <span><span class="ref-journal">American Journal of Medical Genetics. </span>2001;<span class="ref-vol">103</span>:24–31.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11562930" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11562930</span></a>]</div></li><li><div class="bk_ref" id="references.r103">Gross E, Arnold N, Goette J, Schwartz-Boeger U, Kiechle M. A comparison of BRCA 1 mutation analysis by direct sequencing, SSCP and DHPLC. <span><span class="ref-journal">Hum Genet. </span>1999;<span class="ref-vol">105</span>:72–8.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10480358" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10480358</span></a>]</div></li><li><div class="bk_ref" id="references.r104">Gui GP, Hogben RK, Walsh G, A'Hern R, Eeles R. The incidence of breast cancer from screening women according to predicted family history risk: Does annual clinical examination add to mammography? <span><span class="ref-journal">European Journal of Cancer. </span>2001;<span class="ref-vol">37</span>:1668–73.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11527694" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11527694</span></a>]</div></li><li><div class="bk_ref" id="references.r105">Hailey BJ, et al. Breast cancer attitudes, knowledge and screening behavior in women with and without a family history of breast cancer. <span><span class="ref-journal">HEALTH CARE WOMEN INT. </span>2000;<span class="ref-vol">21</span>:701–15.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11813762" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11813762</span></a>]</div></li><li><div class="bk_ref" id="references.r106">Hallowell N. A qualitative study of the information needs of high-risk women undergoing prophylactic oophorectomy. <span><span class="ref-journal">Psycho-oncology. </span>2000;<span class="ref-vol">9</span>(6):486–95.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11180583" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11180583</span></a>]</div></li><li><div class="bk_ref" id="references.r107">Hallowell N, Jacobs I, Richards M, Mackay J, Gore M. Surveillance or Surgery? A description of the factors that influence high risk premenopausal women’s decisions about prophylactic oophorectomy. <span><span class="ref-journal">Journal of Medical Genetics. </span>2001;<span class="ref-vol">38</span>:683–91.</span> [<a href="/pmc/articles/PMC1734749/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC1734749</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11594337" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11594337</span></a>]</div></li><li><div class="bk_ref" id="references.r108">Hallowell N, et al. Talking about chance: the presentation of risk information during genetic counselling for breast and ovarian cancer. <span><span class="ref-journal">Journal of Genetic Counselling. </span>1997;<span class="ref-vol">6</span>:269–86.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26142235" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 26142235</span></a>]</div></li><li><div class="bk_ref" id="references.r109">Hallowell N, et al. Recall of numerical risk estimates and counsellees’ perceptions of the importance of risk information following genetic counselling for beast and ovarian cancer. <span><span class="ref-journal">Psychology Health & Medicine. </span>1997;<span class="ref-vol">2</span>:149–159.</span></div></li><li><div class="bk_ref" id="references.r110">Hallowell N, et al. Women’s need for information before attending genetic counselling for familial breast or ovarian cancer: a questionnaire, interview and observational study. <span><span class="ref-journal">British Medical Journal. </span>1997;<span class="ref-vol">314</span>:281–283.</span> [<a href="/pmc/articles/PMC2125728/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC2125728</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9022494" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 9022494</span></a>]</div></li><li><div class="bk_ref" id="references.r111">Hallowell N. You don’t want to lose your ovaries because you think I might become a man. Women’s perceptions of prophylactic surgery as a cancer risk management option. <span><span class="ref-journal">Psycho-Oncology. </span>1998;<span class="ref-vol">7</span>:263–75.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9638787" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 9638787</span></a>]</div></li><li><div class="bk_ref" id="references.r112">Hallowell N, Murton F. The value of written summaries of genetic consultations. <span><span class="ref-journal">Patient Education and Counselling. </span>1998;<span class="ref-vol">35</span>:27–34.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9832894" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 9832894</span></a>]</div></li><li><div class="bk_ref" id="references.r113">Harper Report Working Group for the Chief Medical Officer. <span class="ref-journal">Genetics and cancer services: Report of a Working Group for the Chief Medical Officer, Department of Health.</span> London: Department of Health; 1998. </div></li><li><div class="bk_ref" id="references.r114">Hartmann LC, Schaid DJ, Woods JE, Crotty TP, Myers JL, Arnold PG, et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. <span><span class="ref-journal">New England Journal of Medicine. </span>1999;<span class="ref-vol">340</span>:77–84.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9887158" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 9887158</span></a>]</div></li><li><div class="bk_ref" id="references.r115">Hartmann LC, Sellers TA, Schaid DJ, Frank TS, Soderberg CL, Sitta DL, et al. Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. <span><span class="ref-journal">Journal of the National Cancer Institute. </span>2001;<span class="ref-vol">93</span>:1633–7.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11698567" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11698567</span></a>]</div></li><li><div class="bk_ref" id="references.r116">Harvie M, Hooper L, Howell AH. Central obesity and breast cancer risk: a systematic review. <span><span class="ref-journal">Obesity Reviews. </span>2003;<span class="ref-vol">4</span>:157–173.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12916817" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 12916817</span></a>]</div></li><li><div class="bk_ref" id="references.r117">Hatcher MB, Fallowfield L, A'Hern R. The psychosocial impact of bilateral prophylactic mastectomy: prospective study using questionnaires and semistructured interviews. <span><span class="ref-journal">British Medical Journal. </span>2001;<span class="ref-vol">322</span>:76–9.</span> [<a href="/pmc/articles/PMC26594/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC26594</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11154619" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11154619</span></a>]</div></li><li><div class="bk_ref" id="references.r118">Hawley W, Nuovo J, DeNeef CP, Carter P. Do oral contraceptive agents affect the risk of breast cancer? A meta -analysis of the case-control reports. <span><span class="ref-journal">Journal of the American Board of Family Practice. </span>1993;<span class="ref-vol">6</span>:123–35.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/8452064" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 8452064</span></a>]</div></li><li><div class="bk_ref" id="references.r119">Hershman, et al. Outcomes of Tamoxifen chemoprevention for breast cancer in very high-risk women: a cost-effectiveness analysis. <span><span class="ref-journal">Journal of Clinical Oncology. </span>2002;<span class="ref-vol">20</span>:9–16.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11773148" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11773148</span></a>]</div></li><li><div class="bk_ref" id="references.r120">Hill ADK, Doyle JM, McDermott EW, O’Higgins NJ. Hereditary breast cancer. <span><span class="ref-journal">British Journal of Surgery. </span>1997;<span class="ref-vol">84</span>(10):1334–1339.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9361585" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 9361585</span></a>]</div></li><li><div class="bk_ref" id="references.r121">Hogervorst FB, et al. Rapid detection of BRCA1 mutations by the protein truncation test. <span><span class="ref-journal">Nature Genetics. </span>1995;<span class="ref-vol">10</span>:208–12.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/7663517" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 7663517</span></a>]</div></li><li><div class="bk_ref" id="references.r122">Holleb AI, Montgomery R, Farrow JH. The hazard of incomplete simple mastectomy. <span><span class="ref-journal">Surgery, Gynecology & Obstetrics. </span>1965:819–22.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/5838290" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 5838290</span></a>]</div></li><li><div class="bk_ref" id="references.r123">Hopwood P, Keeling F, Long A, Pool C, Evans G, Howell A. Psychological support needs for women at high genetic risk of breast cancer: some preliminary indicators. <span><span class="ref-journal">Psycho-oncology. </span>1998;<span class="ref-vol">7</span>:402–412.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9809331" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 9809331</span></a>]</div></li><li><div class="bk_ref" id="references.r124">Hopwood P, Lee A, Shenton A, Baildam A, Brain A, Lalloo F, et al. Clinical follow-up after bilateral risk reducing ('prophylactic') mastectomy: Mental health and body image outcomes. <span><span class="ref-journal">Psycho-Oncology. </span>2000;<span class="ref-vol">9</span>:462–72.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11180581" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11180581</span></a>]</div></li><li><div class="bk_ref" id="references.r125">Hoskins KF, Stopfer JE, Calzone KA, Merajver SD, Rebbeck TR, Garber JE, et al. Assessment and counseling for women with a family history of breast cancer. A guide for clinicians. <span><span class="ref-journal">JAMA. </span>1995;<span class="ref-vol">273</span>:577–85.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/7837392" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 7837392</span></a>]</div></li><li><div class="bk_ref" id="references.r126">Hou MF, Chuang HY, Ou-Yang F, Wang CY, Huang CL, Fan HM, et al. Comparison of breast mammography, sonography and physical examination for screening women at high risk of breast cancer in Taiwan. <span><span class="ref-journal">Ultrasound in Medicine & Biology. </span>2002;<span class="ref-vol">28</span>:415–20.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12049952" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 12049952</span></a>]</div></li><li><div class="bk_ref" id="references.r127">Houlston RS, et al. Family history and risk of breast cancer. <span><span class="ref-journal">Journal of Medical Genetics. </span>1992;<span class="ref-vol">29</span>:154–7.</span> [<a href="/pmc/articles/PMC1015888/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC1015888</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/1552556" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 1552556</span></a>]</div></li><li><div class="bk_ref" id="references.r128">Hughes C, Gomez-Caminero A, Benkendorf J, Kerner J, Isaacs C, Barter J, et al. Ethnic differences in knowledge and attitudes about BRCA1 testing in women at increased risk. <span><span class="ref-journal">PATIENT EDUC COUNS. </span>1997;<span class="ref-vol">32</span>:51–62.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9355572" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 9355572</span></a>]</div></li><li><div class="bk_ref" id="references.r129">Husson G, Herrinton LJ. How accurately does the medical record capture maternal history of cancer? <span><span class="ref-journal">Cancer Epidemiology, Biomarkers & Prevention. </span>2000;<span class="ref-vol">9</span>:765–8.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10919750" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10919750</span></a>]</div></li><li><div class="bk_ref" id="references.r130">Hyland F, Kinmonth AL, Marteau TM, Griffin S, Murrell P, Spiegelhalter D, et al. Raising concerns about family history of breast cancer in primary care consultations: prospective, population based study. Women's Concerns Study Group. <span><span class="ref-journal">BMJ. </span>2001;<span class="ref-vol">322</span>:27–8.</span> [<a href="/pmc/articles/PMC26605/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC26605</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11141150" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11141150</span></a>]</div></li><li><div class="bk_ref" id="references.r131">
|
||
IBIS Investigators. First results from the International Breast Cancer Intervention Study (IBIS-1): a randomised prevention trial. <span><span class="ref-journal">Lancet. </span>2002;<span class="ref-vol">360</span>:817–24.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12243915" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 12243915</span></a>]</div></li><li><div class="bk_ref" id="references.r132">
|
||
International Agency for Research on Cancer (IARC).
|
||
IARC Press;
|
||
Lyon: <span><span class="ref-journal">Breast cancer screening. </span>2002</span></div></li><li><div class="bk_ref" id="references.r133">
|
||
International Agency for Research on Cancer (IARC).
|
||
IARC Press;
|
||
Lyon: <span><span class="ref-journal">IARC Handbooks of Cancer Prevention: Volume 6: Weight Control and Physical Activity. </span>2002</span></div></li><li><div class="bk_ref" id="references.r134">Jacobsen PB, Valdimarsdottir HB, Brown KL, Offit K. Decision-making about genetic testing among women at familial risk for breast cancer. <span><span class="ref-journal">Psychosomatic Medicine. </span>1997;<span class="ref-vol">59</span>:459–66.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9316177" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 9316177</span></a>]</div></li><li><div class="bk_ref" id="references.r135">Josephson U, Wickman M, Sandelin K. Initial experiences of women from hereditary breast cancer families after bilateral prophylactic mastectomy: a retrospective study. <span><span class="ref-journal">European Journal of Surgical Oncology. </span>2000;<span class="ref-vol">26</span>:351–6.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10873354" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10873354</span></a>]</div></li><li><div class="bk_ref" id="references.r136">Julian-Reynier C, Eisinger F, Chabal F, Lasset C, Nogues C, Stoppa-Lyonnet D, et al. Disclosure to the family of breast/ovarian cancer genetic test results: patient's willingness and associated factors. <span><span class="ref-journal">American Journal of Medical Genetics. </span>2000;<span class="ref-vol">94</span>:13–8.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10982476" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10982476</span></a>]</div></li><li><div class="bk_ref" id="references.r137">Julian-Reynier C, Eisinger F, Chabal F, Aurran Y, Noguès C, Vennin P, Bignon Y-J, Machelard–Roumagnac M, Maugard-Louboutin C, Serin D, Versini S, Mercuri M, Sobol H. Cancer genetic clinics: target population and consultees’ expectations. <span><span class="ref-journal">European Journal of Cancer. </span>1996;<span class="ref-vol">32A</span>:398–403.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/8814681" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 8814681</span></a>]</div></li><li><div class="bk_ref" id="references.r138">Julian-Reynier C, Welkenhuysen M, Hagoel L, et al. on behalf of the CRISCOM* Working Group Risk communication strategies: state of the art and effectiveness in the context of cancer genetics services. <span><span class="ref-journal">Eur J Human Genetics. </span>2003;<span class="ref-vol">11</span>:725–36.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/14512961" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 14512961</span></a>]</div></li><li><div class="bk_ref" id="references.r139">Kauff ND, et al. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. <span><span class="ref-journal">New England Journal of Medicine. </span>2002;<span class="ref-vol">346</span>:1609–15.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12023992" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 12023992</span></a>]</div></li><li><div class="bk_ref" id="references.r140">Kelly PT. Counselling needs of women with a maternal history of breast cancer. <span><span class="ref-journal">Patient Counselling and Health Education. </span>1980;<span class="ref-vol">2</span>:118–124.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10249188" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10249188</span></a>]</div></li><li><div class="bk_ref" id="references.r141">Kelly PT. Informational needs of individuals and families with hereditary cancers. <span><span class="ref-journal">Seminars in Oncology Nursing. </span>1992;<span class="ref-vol">8</span>:288–292.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/1480860" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 1480860</span></a>]</div></li><li><div class="bk_ref" id="references.r142">Kerlikowske K, Carney PA, Geller B, Mandelson MT, Taplin SH, et al. Performance of screening Mammography among Women with and without a First Degree Relative with Breast Cancer. <span><span class="ref-journal">Ann Intern Med. </span>2000;<span class="ref-vol">133</span>:855–63.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11103055" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11103055</span></a>]</div></li><li><div class="bk_ref" id="references.r143">Kerlikowske K, Grady D, Barclay J, Sickles EA, Eaton A, Ernster V. Positive predictive value of screening mammography by age and family history of breast cancer. <span><span class="ref-journal">JAMA. </span>1993;<span class="ref-vol">270</span>:2444–50.</span> (see comments) [<a href="https://pubmed.ncbi.nlm.nih.gov/8230621" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 8230621</span></a>]</div></li><li><div class="bk_ref" id="references.r144">Kerlikowske K, Grady D, Barclay J, Sickles EA, Ernster V. Effect of age, breast density, and family history on the sensitivity of first screening mammography.(comment). <span><span class="ref-journal">JAMA. </span>1996;<span class="ref-vol">276</span>:33–8.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/8667536" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 8667536</span></a>]</div></li><li><div class="bk_ref" id="references.r145">Kerr B, Foulkes WD, Cade D, Hadfield L, Hopwood P, Serruya C, et al. False family history of breast cancer in the family cancer clinic. <span><span class="ref-journal">European Journal of Surgical Oncology. </span>1998;<span class="ref-vol">24</span>:275–9.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9724992" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 9724992</span></a>]</div></li><li><div class="bk_ref" id="references.r146">Khuder SA, et al. Smoking and breast cancer: a meta-analysis. <span><span class="ref-journal">Reviews on Environmental Health. </span>2001;<span class="ref-vol">16</span>:253–61.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12041881" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 12041881</span></a>]</div></li><li><div class="bk_ref" id="references.r147">King MC, Wieand S, Hale K, Lee M, Walsh T, Owens K, et al. Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial. <span><span class="ref-journal">JAMA. </span>2001;<span class="ref-vol">286</span>:2251–6.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11710890" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11710890</span></a>]</div></li><li><div class="bk_ref" id="references.r148">Kinney AY, Croyle RT, Dudley WN, Bailey CA, Pelias MK, Neuhausen SL. Knowledge, attitudes, and interest in breast-ovarian cancer gene testing: a survey of a large African-American kindred with a BRCA1 mutation. <span><span class="ref-journal">Preventive Medicine. </span>2001;<span class="ref-vol">33</span>:543–51.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11716649" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11716649</span></a>]</div></li><li><div class="bk_ref" id="references.r149">Klip H, Burger CW, Kenemans P, van Leeuwen FE. Cancer risk associated with subfertility and ovulation induction: a review. <span><span class="ref-journal">Cancer Causes and Control. </span>2000;<span class="ref-vol">11</span>:319–344.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10843444" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10843444</span></a>]</div></li><li><div class="bk_ref" id="references.r150">Kollias J, Sibberingg DM, Blamey RW, Holland PA, Obuszko Z, Wilson AR, et al. Screening women aged less than 50 years with a family history of breast cancer. <span><span class="ref-journal">European Journal of Cancer. </span>1998;<span class="ref-vol">34</span>:878–83.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9797701" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 9797701</span></a>]</div></li><li><div class="bk_ref" id="references.r151">Koster JP, Gotzsche PC. Regular self-examination or clinical examination for early detection of breast cancer. <span><span class="ref-journal">The Cochrane Library. </span>2003;<span class="ref-vol">3</span>:1–13.</span> [<a href="/pmc/articles/PMC7387360/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC7387360</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12804462" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 12804462</span></a>]</div></li><li><div class="bk_ref" id="references.r152">Kozlowski P, Krzyzosiak WJ. Combined SSCO/duplex analysis by capillary electrophoresis for more efficient mutation detection. <span><span class="ref-journal">Nucleic Acids Res. </span>2001;<span class="ref-vol">29</span>:E71.</span> [<a href="/pmc/articles/PMC55818/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC55818</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11452040" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11452040</span></a>]</div></li><li><div class="bk_ref" id="references.r153">Kreuter MW. Dealing with competing and conflicting risks in cancer communication. <span><span class="ref-journal">Journal of the National Cancer Institute Monograph. </span>1999;<span class="ref-vol">25</span>:27–35.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10854454" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10854454</span></a>]</div></li><li><div class="bk_ref" id="references.r154">Kuhl CK, Schmutzler RK, Leutner CC, Kempe A, Wardelmann E, Hocke A, et al. Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results. <span><span class="ref-journal">Radiology. </span>2000;<span class="ref-vol">215</span>:267–79.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10751498" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10751498</span></a>]</div></li><li><div class="bk_ref" id="references.r155">Lalloo F, Boggis CR, Evans DG, Shenton A, Threlfall AG, Howell A. Screening by mammography, women with a family history of breast cancer. <span><span class="ref-journal">European Journal of Cancer. </span>1998;<span class="ref-vol">34</span>:937–40.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9797712" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 9797712</span></a>]</div></li><li><div class="bk_ref" id="references.r156">Lalloo F, Varley J, Ellis D, O’Dair L, Pharoah P, Evans DGR.
|
||
the early onset breast cancer study Group. Family history is predictive of pathogenic mutations in BRCA1, BRCA2 and TP53 with high penetrancegg in a population based study of very early onset breast cancer. <span><span class="ref-journal">Lancet. </span>2003;<span class="ref-vol">361</span>:1011–1012.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12672316" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 12672316</span></a>]</div></li><li><div class="bk_ref" id="references.r157">Lancaster JM, et al. Dideoxy fingerprinting assay for BRCA1 mutation analysis. <span><span class="ref-journal">Molecular Carcinogenesis. </span>1997;<span class="ref-vol">19</span>:176–9.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9254884" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 9254884</span></a>]</div></li><li><div class="bk_ref" id="references.r158">Law J, Faulkner K. Cancers detected and induced and associated risk and benefit in a breast screening programme. <span><span class="ref-journal">British Journal of Radiology. </span>2001;<span class="ref-vol">74</span>:1121–7.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11777770" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11777770</span></a>]</div></li><li><div class="bk_ref" id="references.r159">Law J. Cancers detected and induced in mammographic screening: new screening schedules and younger women with family history. <span><span class="ref-journal">British Journal of Radiology. </span>1997;<span class="ref-vol">70</span>:62–9.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9059297" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 9059297</span></a>]</div></li><li><div class="bk_ref" id="references.r160">Leach FS, Nicolaides NC, Papadopoulos N, et al. Mutation of a mut S homolog in hereditary non polyposis colorectal cancer. <span><span class="ref-journal">Cell. </span>1993;<span class="ref-vol">75</span>:1215–1225.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/8261515" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 8261515</span></a>]</div></li><li><div class="bk_ref" id="references.r161">Leggatt V, Mackay J, Marteau TM, Yates JR. The psychological impact of a cancer family history questionnaire completed in general practice. <span><span class="ref-journal">Journal of Medical Genetics. </span>2000;<span class="ref-vol">37</span>:470–2.</span> [<a href="/pmc/articles/PMC1734599/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC1734599</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10928860" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10928860</span></a>]</div></li><li><div class="bk_ref" id="references.r162">Leggatt V, Mackay J, Yates JR. Evaluation of questionnaire on cancer family history in identifying patients at increased genetic risk in general practice. <span><span class="ref-journal">BMJ. </span>1999;<span class="ref-vol">319</span>:757–8.</span> (see comments) [<a href="/pmc/articles/PMC28230/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC28230</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10488003" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10488003</span></a>]</div></li><li><div class="bk_ref" id="references.r163">Lerman C, Daly M, Masny A, Balshem A. Attitudes about genetic testing for breast-ovarian cancer susceptibility. <span><span class="ref-journal">Journal of Clinical Oncology. </span>1994;<span class="ref-vol">12</span>:843–50.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/8151327" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 8151327</span></a>]</div></li><li><div class="bk_ref" id="references.r164">Lerman C, Hughes C, Lemon SJ, Main D, Snyder C, Durham C, et al. What you don't know can hurt you: adverse psychologic effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testing. <span><span class="ref-journal">Journal of Clinical Oncology. </span>1998;<span class="ref-vol">16</span>:1650–4.</span> (see comments) [<a href="https://pubmed.ncbi.nlm.nih.gov/9586874" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 9586874</span></a>]</div></li><li><div class="bk_ref" id="references.r165">Lerman C, Narod S, Schulman K, Hughes C, Gomez-Caminero A, Bonney G, et al. BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. <span><span class="ref-journal">JAMA. </span>1996;<span class="ref-vol">275</span>:1885–92.</span> (see comments) [<a href="https://pubmed.ncbi.nlm.nih.gov/8648868" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 8648868</span></a>]</div></li><li><div class="bk_ref" id="references.r166">Lerman C, Seay J, Balshem A, Audrain J. Interest in genetic testing among first-degree relatives of breast cancer patients. <span><span class="ref-journal">American Journal of Medical Genetics. </span>1995;<span class="ref-vol">57</span>:385–92.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/7677139" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 7677139</span></a>]</div></li><li><div class="bk_ref" id="references.r167">Lerman C, et al. The influence of psychological distress on use of genetic testing for cancer risk. <span><span class="ref-journal">Journal of Consulting & Clinical Psychology. </span>1997;<span class="ref-vol">65</span>:414–20.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9170764" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 9170764</span></a>]</div></li><li><div class="bk_ref" id="references.r168">Lindberg NM, Wellisch D. Anxiety and compliance among women at risk for breast cancer. <span><span class="ref-journal">Annals of Behavioral Medicine. </span>2001;<span class="ref-vol">23</span>:298–303.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11761347" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11761347</span></a>]</div></li><li><div class="bk_ref" id="references.r169">Lipworth L, et al. History of breast-feeding in relation to breast cancer risk: a review of the epidemiologic literature. <span><span class="ref-journal">Journal of National Cancer Institute. </span>2000;<span class="ref-vol">92</span>:302–12.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10675379" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10675379</span></a>]</div></li><li><div class="bk_ref" id="references.r170">Lloyd SM, Watson M, Oaker G, Sacks N, Della Rovere UQ, Gui G. Understanding the experience of prophylactic bilateral mastectomy: A qualitative study of ten women. <span><span class="ref-journal">Psycho-Oncology. </span>2000;<span class="ref-vol">9</span>:473–85.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11180582" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11180582</span></a>]</div></li><li><div class="bk_ref" id="references.r171">Loader S, Levenkron JC, Rowley PT. Genetic testing for breast-ovarian cancer susceptibility: a regional trial. <span><span class="ref-journal">Genetic Testing. </span>1998;<span class="ref-vol">2</span>:305–13.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10464609" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10464609</span></a>]</div></li><li><div class="bk_ref" id="references.r172">Lodder L, Frets PG, Trijsburg RW, Tibben A, Meijers-Heijboer EJ, Duivenvoorden HJ, et al. Men at risk of being a mutation carrier for hereditary breast/ovarian cancer: an exploration of attitudes and psychological functioning during genetic testing. <span><span class="ref-journal">European Journal of Human Genetics. </span>2001;<span class="ref-vol">9</span>:492–500.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11464240" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11464240</span></a>]</div></li><li><div class="bk_ref" id="references.r173">Lodder LN, Frets PG, Trijsberg RW, Meijers-Heijboer EJ, et al. Presymptomatic testing for BRCA1 and BRCA2: how distressing are the pre-test weeks? <span><span class="ref-journal">J Med Genet. </span>1999;<span class="ref-vol">36</span>:906–13.</span> [<a href="/pmc/articles/PMC1734277/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC1734277</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10593998" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10593998</span></a>]</div></li><li><div class="bk_ref" id="references.r174">Longnecker MP. Alcohol beverage consumption in relation to risk of breast cancer: meta-analysis and review. <span><span class="ref-journal">Cancer Causes & Control. </span>1994;<span class="ref-vol">5</span>:73–82.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/8123780" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 8123780</span></a>]</div></li><li><div class="bk_ref" id="references.r175">Longnecker MP, et al. A meta-analysis of alcohol consumption in relation to risk of breast cancer. <span><span class="ref-journal">JAMA. </span>1988;<span class="ref-vol">260</span>:652–6.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/3392790" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 3392790</span></a>]</div></li><li><div class="bk_ref" id="references.r176">Lynch HT, Lemon SJ, Durham C, Tinley ST, Connolly C, Lynch JF, et al. A descriptive study of BRCA1 testing and reactions to disclosure of test results. <span><span class="ref-journal">Cancer. </span>1997;<span class="ref-vol">79</span>:2219–28.</span> (see comments) [<a href="https://pubmed.ncbi.nlm.nih.gov/9179070" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 9179070</span></a>]</div></li><li><div class="bk_ref" id="references.r177">Macmillan RD. Screening women with a family history of breast cancer--results from the British Familial Breast Cancer Group. <span><span class="ref-journal">European Journal of Surgical Oncology. </span>2000;<span class="ref-vol">26</span>:149–52.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10744933" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10744933</span></a>]</div></li><li><div class="bk_ref" id="references.r178">Malkin D, Li FP, Strong LC, et al. Germline <em>TP53</em> mutations in cancer families. <span><span class="ref-journal">Science. </span>1990;<span class="ref-vol">250</span>:1233–1238.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/1978757" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 1978757</span></a>]</div></li><li><div class="bk_ref" id="references.r179">Marchbanks PA, et al. Oral contraceptives and the risk of breast cancer. <span><span class="ref-journal">New England Journal of Medicine. </span>2002;<span class="ref-vol">346</span>:2025–32.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12087137" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 12087137</span></a>]</div></li><li><div class="bk_ref" id="references.r180">Markoff A, et al. Comparison of conformation-sensitive gel electrophoresis and single-strand conformation polymorphism analysis for detection of mutations in the BRCA1 gene using optimized conformation analysis protocols. <span><span class="ref-journal">EUR J HUM GENET. </span>1998;<span class="ref-vol">6</span>:145–50.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9781059" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 9781059</span></a>]</div></li><li><div class="bk_ref" id="references.r181">McAllister M, O’Malley K, Hopwood P, et al. Management of women with a family history of breast cancer in the North West Region: training for implementing a vision of the future. <span><span class="ref-journal">J Med Genet. </span>2002;<span class="ref-vol">39</span>:531–535.</span> [<a href="/pmc/articles/PMC1735171/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC1735171</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12114490" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 12114490</span></a>]</div></li><li><div class="bk_ref" id="references.r182">McCaul KD, Branstetter AD, Schroeder DM, Glasgow RE. What is the relationship between breast cancer risk and mammography screening? A meta-analytic review. <span><span class="ref-journal">Health Psychology. </span>1996;<span class="ref-vol">15</span>:423–9.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/8973921" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 8973921</span></a>]</div></li><li><div class="bk_ref" id="references.r183">McPherson K, Steel CM, Dixon JM. Breast cancer – epidemiology, risk factors, and genetics. <span><span class="ref-journal">BMJ. </span>2000;<span class="ref-vol">321</span>:624–628.</span> [<a href="/pmc/articles/PMC1118507/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC1118507</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10977847" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10977847</span></a>]</div></li><li><div class="bk_ref" id="references.r184">McTiernan A, Gilligan MA, Redmond C. Assessing individual risk for breast cancer: risky business. (Review) (60 refs). <span><span class="ref-journal">Journal of Clinical Epidemiology. </span>1997;<span class="ref-vol">50</span>:547–56.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9180647" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 9180647</span></a>]</div></li><li><div class="bk_ref" id="references.r185">McTiernan A, Kuniyuki A, Yasui Y, Bowen D, Burke W, Culver JB, et al. Comparisons of two breast cancer risk estimates in women with a family history of breast cancer. <span><span class="ref-journal">Cancer Epidemiology, Biomarkers & Prevention. </span>2001;<span class="ref-vol">10</span>:333–8.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11319173" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11319173</span></a>]</div></li><li><div class="bk_ref" id="references.r186">Meijers-Heijboer EJ, Verhoog LC, Brekelmans CT, Seynaeve C, Tilanus-Linthorst MM, Wagner A, et al. Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation. <span><span class="ref-journal">Lancet. </span>2000;<span class="ref-vol">355</span>:2015–20.</span> (see comments) [<a href="https://pubmed.ncbi.nlm.nih.gov/10885351" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10885351</span></a>]</div></li><li><div class="bk_ref" id="references.r187">Meijers-Heijboer EJ, Verhoog LC, Brekelmans CT, Seynaeve C, Tilanus-Linthorst MM, Wagner A, et al. Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation. <span><span class="ref-journal">Lancet. </span>2000;<span class="ref-vol">355</span>:2015–20.</span> (see comments) [<a href="https://pubmed.ncbi.nlm.nih.gov/10885351" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10885351</span></a>]</div></li><li><div class="bk_ref" id="references.r188">Meijers-Heijboer H, van Geel B, van Putten WLJ, Henzen-Logmans SC, Seynaeve C, Menke-Pluymers MBE, et al. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. <span><span class="ref-journal">New England Journal of Medicine. </span>2001;<span class="ref-vol">345</span>:159–64.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11463009" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11463009</span></a>]</div></li><li><div class="bk_ref" id="references.r189">Meiser B, Butow P, Barratt A, Friedlander M, Gattas M, Kirk J, et al. Attitudes toward prophylactic oophorectomy and screening utilization in women at increased risk of developing hereditary breast/ovarian cancer. <span><span class="ref-journal">Gynecologic Oncology. </span>1999;<span class="ref-vol">75</span>:122–9.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10502438" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10502438</span></a>]</div></li><li><div class="bk_ref" id="references.r190">Meiser B, Butow P, Barratt A, Friedlander M, Kirk J, Gaff C, et al. Breast cancer screening uptake in women at increased risk of developing hereditary breast cancer. <span><span class="ref-journal">Breast Cancer Research & Treatment. </span>2000;<span class="ref-vol">59</span>:101–11.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10817345" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10817345</span></a>]</div></li><li><div class="bk_ref" id="references.r191">Meiser B, Butow P, Friedlander M, Barratt A, Schnieden V, Watson M, et al. Psychological impact of genetic testing in women from high-risk breast cancer families. <span><span class="ref-journal">European Journal of Cancer. </span>2002;<span class="ref-vol">38</span>:2025–31.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12376208" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 12376208</span></a>]</div></li><li><div class="bk_ref" id="references.r192">Meiser B, Tiller K, et al. Psychological impact of prophylactic oophorectomy in women at increased risk of developing ovarian cancer. <span><span class="ref-journal">Psycho-oncology. </span>2000;<span class="ref-vol">9</span>(6):496–503.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11180584" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11180584</span></a>]</div></li><li><div class="bk_ref" id="references.r193">Meiser B, Halliday JL. What is the impact of genetic counselling in women at increased risk of developing hereditary breast cancer? A meta-analytic review. <span><span class="ref-journal">Social Science & Medicine. </span>2002;<span class="ref-vol">54</span>:1463–70.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12061481" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 12061481</span></a>]</div></li><li><div class="bk_ref" id="references.r194">
|
||
Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study. <span><span class="ref-journal">The Lancet. </span>2003;<span class="ref-vol">362</span>:419–27.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12927427" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 12927427</span></a>]</div></li><li><div class="bk_ref" id="references.r195">Moller P, Borg A, Evans DG, Haites N, et al. Survival in prospectively ascertained familial breast cancer: Analysis of a series of stratified by tumour characteristics, BRCA mutations and oophorectomy. <span><span class="ref-journal">International-Journal-of-Cancer. </span>2002;<span class="ref-vol">101</span>:555–9.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12237897" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 12237897</span></a>]</div></li><li><div class="bk_ref" id="references.r196">Montagna M, Santacatterina M, Torri A, Menin C, Zullato D, Chieco-Bianchi L. Identification of a 3kb Alu-mediated BRCA 1 gene rearrangement in two breast/ovarian cancer families. <span><span class="ref-journal">Oncogene. </span>1999;<span class="ref-vol">18</span>:4160–5.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10435598" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10435598</span></a>]</div></li><li><div class="bk_ref" id="references.r197">Mueller C, Haworth A. <span class="ref-journal">Draft best practice guidelines for molecular analysis of hereditary breast and ovarian cancer, European Molecular Genetics Quality Network.</span> 2001. [accessed 18.3.03]. <a href="http://www.emqn.org/guidelines/brca_eu.php" ref="pagearea=cite-ref&targetsite=external&targetcat=link&targettype=uri">http://www<wbr style="display:inline-block"></wbr>.emqn.org/guidelines/brca_eu<wbr style="display:inline-block"></wbr>.php</a>.</div></li><li><div class="bk_ref" id="references.r198">Murday V. Genetic counselling in the cancer family clinic. <span><span class="ref-journal">European Journal of Cancer. </span>1994;<span class="ref-vol">30A</span>:2012–5.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/7734215" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 7734215</span></a>]</div></li><li><div class="bk_ref" id="references.r199">Myles J, Duffy S, Nixon R, Boggis C, Howell A, Shenton A, et al. Initial results of a study into the effectiveness of breast cancer screening in a population identified to be at high risk. <span><span class="ref-journal">Revue d Epidemiologie et de Sante Publique. </span>2001;<span class="ref-vol">49</span>:471–5.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11845096" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11845096</span></a>]</div></li><li><div class="bk_ref" id="references.r200">Nagata C, et al. Effects of menstrual and reproductive factors on the risk of breast cancer: meta-analysis of the case control studies in Japan. <span><span class="ref-journal">Japanese Journal of Cancer Research. </span>1995;<span class="ref-vol">86</span>:910–5.</span> [<a href="/pmc/articles/PMC5920604/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC5920604</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7493908" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 7493908</span></a>]</div></li><li><div class="bk_ref" id="references.r201">Narod SA, et al. Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. <span><span class="ref-journal">Lancet. </span>2000;<span class="ref-vol">356</span>:1876–81.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11130383" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11130383</span></a>]</div></li><li><div class="bk_ref" id="references.r202">Narod SA, et al. Oral Contraceptives and the Risk of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers. <span><span class="ref-journal">J Natl Cancer Inst. </span>2002;<span class="ref-vol">94</span>:1773–9.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12464649" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 12464649</span></a>]</div></li><li><div class="bk_ref" id="references.r203">National Surgical Adjuvant Breast and Bowel Project. <span class="ref-journal">NSABP Protocol P-1: a clinical trial to determine the worth of tamoxifen for preventing breast cancer.</span> Pittsburgh, PA: NSABP; 1992. </div></li><li><div class="bk_ref" id="references.r204">Negri E, et al. Risk factors for breast cancer: pooled results from three Italian case-control studies. <span><span class="ref-journal">American Journal of Epidemiology. </span>1988;<span class="ref-vol">128</span>:1207–15.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/3195562" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 3195562</span></a>]</div></li><li><div class="bk_ref" id="references.r205">Nelen MR, Padberg GW, Peeters EAJ, et al. Localisation of the gene for Cowden disease to chromosome lOq22–23. <span><span class="ref-journal">Nature Genet. </span>1996;<span class="ref-vol">13</span>:114–116.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/8673088" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 8673088</span></a>]</div></li><li><div class="bk_ref" id="references.r206">Newman B, Austin MA, Lee M, King M. Inheritance of human breast cancer: Evidence for autosomal dominant transmission in high-risk families. <span><span class="ref-journal">Proc Natl Acad Sci. </span>1988;<span class="ref-vol">85</span>:3044–3048.</span> [<a href="/pmc/articles/PMC280139/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC280139</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/3362861" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 3362861</span></a>]</div></li><li><div class="bk_ref" id="references.r207">National Health Service Breast Screening Programme (NHSBSP). <span class="ref-journal">Review of Radiation Risk in Breast Screening: Report by a joint working party of the NHSBSP National Coordinating Group for Physics Quality Assurance and the National Radiological Protection Board.</span> NHSBSP Publication No 54. Sheffield: NHS Cancer Screening Programmes; 2003. </div></li><li><div class="bk_ref" id="references.r208">NHS Cancer Screening Programmes and Cancer Research Campaign. <span class="ref-journal">Familial Breast and Ovarian Cancer: an information pack for primary care.</span> London: Department of Health; 2001. </div></li><li><div class="bk_ref" id="references.r209"><span class="ref-journal">NICE Guideline Development Process Manuals.</span> London: National Institute for Clinical Excellence; <br /><span class="ref-journal">Guideline Development Process - Information for National Collaborating Centres and Guideline Development Groups.</span> 2001. <br /><span class="ref-journal">Guideline development Process - Information for Stakeholders.</span> 2002. <br /><span class="ref-journal">Guideline Development Process - Information for the Public and the NHS.</span> 2001. </div></li><li><div class="bk_ref" id="references.r210">Nicolaides NC, Papadopoulos N, Liu B, et al. Mutation of two PMS homologs in hereditary non polyposis colorectal cancer. <span><span class="ref-journal">Nature. </span>1994;<span class="ref-vol">371</span>:75–80.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/8072530" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 8072530</span></a>]</div></li><li><div class="bk_ref" id="references.r211">Nixon RM, Pharoah P, Tabar L, Krusemo UB, Duffy SW, Prevost TC, et al. Mammographic screening in women with a family history of breast cancer: some results from the Swedish two-county trial. <span><span class="ref-journal">Revue d Epidemiologie et de Sante Publique. </span>2000;<span class="ref-vol">48</span>:325–31.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11011299" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11011299</span></a>]</div></li><li><div class="bk_ref" id="references.r212">Noorani HZ, McGahan L. <span class="ref-journal">Predictive genetic testing for breast and prostate cancer.</span> Ottawa: Canadian Coordinating Office for Health Technology Assessment/Office Canadien de Coordination de 'Evaluation des Technologies de la Sante. Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 1999. 1895561698. Technology Report Is. 85. 1999. Ref Type: Report.</div></li><li><div class="bk_ref" id="references.r213">O’Driscoll D, Warren R, Mackay J, Britton P, Day NE. Screening with breast ultrasound in a population at moderate risk due to family history. <span><span class="ref-journal">J Med Screen. </span>2001;<span class="ref-vol">8</span>:106–9.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11480440" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11480440</span></a>]</div></li><li><div class="bk_ref" id="references.r214">Office for National Statistics. <span class="ref-journal">Breast cancer: incidence rate rises while death rate falls.</span> 2003. [accessed 5 December 2003]. <a href="http://www.statistics.gov.uk/cci/nugget.asp?id=575" ref="pagearea=cite-ref&targetsite=external&targetcat=link&targettype=uri">http://www<wbr style="display:inline-block"></wbr>.statistics<wbr style="display:inline-block"></wbr>.gov.uk/cci/nugget.asp?id=575</a>. released 31 October 2003 at 9.30am.</div></li><li><div class="bk_ref" id="references.r215">Office for National Statistics. <span class="ref-journal">Cancer trends in England and Wales, 1950–1999, Studies on Medical and Population Subjects No 66.</span> London: The Stationery Office; 2001. </div></li><li><div class="bk_ref" id="references.r216">Ottman R, et al. Practical guide for estimating risk for familial breast cancer. <span><span class="ref-journal">Lancet. </span>1983;<span class="ref-vol">2</span>:556–8.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/6136703" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 6136703</span></a>]</div></li><li><div class="bk_ref" id="references.r217">Palmer JR, Rosenberg L. Cigarette smoking and the risk of breast cancer. <span><span class="ref-journal">Epidemiologic Reviews. </span>1993;<span class="ref-vol">15</span>:145–56.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/8405197" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 8405197</span></a>]</div></li><li><div class="bk_ref" id="references.r218">Papadopoulos N, Nicolaides NC, Wei Y-F, et al. Mutation of a Mut L homolog in hereditary colon cancer. <span><span class="ref-journal">Science. </span>1994;<span class="ref-vol">263</span>:1625–1629.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/8128251" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 8128251</span></a>]</div></li><li><div class="bk_ref" id="references.r219">Parent ME, Ghadirian P, Lacroix A, Perret C. The reliability of recollections of family history: implications for the medical provider. <span><span class="ref-journal">Journal of Cancer Education. </span>1997;<span class="ref-vol">12</span>:114–20.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9229275" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 9229275</span></a>]</div></li><li><div class="bk_ref" id="references.r220">Patenaude AF, et al. Acceptance of invitations for p53 and BRCA1 predisposition testing: factors influencing potential utilization of cancer genetic testing. <span><span class="ref-journal">Psyco-Oncology. </span>1996;<span class="ref-vol">5</span>:241–50.</span></div></li><li><div class="bk_ref" id="references.r221">Pennisi VR, Capozzi A. Subcutaneous mastectomy data: a final statistical analysis of 1500 patients. <span><span class="ref-journal">Aesthetic Plastic Surgery. </span>1989;<span class="ref-vol">13</span>:15–21.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/2728994" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 2728994</span></a>]</div></li><li><div class="bk_ref" id="references.r222">Peto J, Mack TM. High constant incidence in twins and other relatives of women with breast cancer. <span><span class="ref-journal">Nat Genet. </span>2000;<span class="ref-vol">26</span>:411–4.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11101836" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11101836</span></a>]</div></li><li><div class="bk_ref" id="references.r223">Pharoah PDP, Day NE, Duffy S, Easton DF, Ponder BAJ. Family history and the risk of breast cancer: a systematic review and meta-analysis. <span><span class="ref-journal">International Journal of Cancer. </span>1997;<span class="ref-vol">71</span>:800–809.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9180149" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 9180149</span></a>]</div></li><li><div class="bk_ref" id="references.r224">Powles T, Eeles R, Ashley S, Easton D, Chang J, Dowsett M, et al. Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial. <span><span class="ref-journal">Lancet. </span>1998;<span class="ref-vol">352</span>:98–101.</span> (see comments) [<a href="https://pubmed.ncbi.nlm.nih.gov/9672274" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 9672274</span></a>]</div></li><li><div class="bk_ref" id="references.r225">Qureshi N, et al. A randomized controlled trial to assess the psychological impact of a family history screening questionnaire in general practice. <span><span class="ref-journal">Fam Pract. </span>2001;<span class="ref-vol">18</span>:78–83.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11145633" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11145633</span></a>]</div></li><li><div class="bk_ref" id="references.r226">R&D Office of the Anglia & Oxford NHS Executive and the Unit for Public Health Genetics, Cambridge. <span class="ref-journal">Report of consensus meeting on the management of women with a family history of breast cancer.</span> 1998. [Accessed 2002]. <a href="http://www.medinfo.cam.ac.uk/phgu/info_database/public_documents/breastcaconsen.asp" ref="pagearea=cite-ref&targetsite=external&targetcat=link&targettype=uri">http://www<wbr style="display:inline-block"></wbr>.medinfo.cam<wbr style="display:inline-block"></wbr>.ac.uk/phgu/info_database<wbr style="display:inline-block"></wbr>/public_documents/breastcaconsen<wbr style="display:inline-block"></wbr>.asp</a>.</div></li><li><div class="bk_ref" id="references.r227">Rebbeck TR, Levin MA, Eisen A, et al. Breast cancer risk after bilateral prophylatic oophorectomy in BRCA1 mutation carriers. <span><span class="ref-journal">Journal of the National Cancer Institute. </span>1999;<span class="ref-vol">91</span>:1475–9.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10469748" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10469748</span></a>]</div></li><li><div class="bk_ref" id="references.r228">Rebbeck TR, et al. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. <span><span class="ref-journal">New England Journal of Medicine. </span>2002;<span class="ref-vol">346</span>:1616–22.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12023993" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 12023993</span></a>]</div></li><li><div class="bk_ref" id="references.r229">Rees, Bath Meeting the information needs of adult duaghters of women with early breast cancer. <span><span class="ref-journal">Cancer Nursing. </span>2000;<span class="ref-vol">23</span>:71–79.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10673810" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10673810</span></a>]</div></li><li><div class="bk_ref" id="references.r230">Reichelt JG, Dahl AA, Heimdal K, Moller P. Uptake of genetic testing and pre-test levels of mental distress in Norwegian families with known BRCA1 mutations. <span><span class="ref-journal">Disease Markers. </span>1999;<span class="ref-vol">15</span>:139–43.</span> [<a href="/pmc/articles/PMC3850804/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC3850804</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10595268" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10595268</span></a>]</div></li><li><div class="bk_ref" id="references.r231">Richards CS, Ward PA, Roa BB, Friedman LC, Boyd AA, Kuenzli G, et al. Screening for 185delAG in the Ashkenazim. <span><span class="ref-journal">American Journal of Human Genetics. </span>1997;<span class="ref-vol">60</span>:1085–98.</span> [<a href="/pmc/articles/PMC1712425/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC1712425</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9150156" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 9150156</span></a>]</div></li><li><div class="bk_ref" id="references.r232">Richards MPM, Hallowell N, Green JM, Murton F, Statham H. Counselling families with hereditary breast and ovarian cancer: A psychosocial perspective. <span><span class="ref-journal">J Genet Counsel. </span>1995;<span class="ref-vol">4</span>:219–233.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24234371" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 24234371</span></a>]</div></li><li><div class="bk_ref" id="references.r233">Richards MPM, Hallowell N, Green JM, et al. Counselling families with hereditary breast and ovarian cancer: a psychosocial perspective. <span><span class="ref-journal">J Genet Couns. </span>1995;<span class="ref-vol">4</span>:219–33.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24234371" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 24234371</span></a>]</div></li><li><div class="bk_ref" id="references.r234">Richards MPM. Genetic counselling for those with a family history of breast or ovarian cancer. <span><span class="ref-journal">Acta Oncologica. </span>1999;<span class="ref-vol">3</span>:559–565.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10427943" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10427943</span></a>]</div></li><li><div class="bk_ref" id="references.r235">Richter S, et al. One step direct detection of recurrent mutations in the breast cancer susceptibility gene, BRCA1. <span><span class="ref-journal">Int J Oncol. </span>1998;<span class="ref-vol">12</span>:1263–7.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9592184" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 9592184</span></a>]</div></li><li><div class="bk_ref" id="references.r236">Robinson MD, Chu CE, Turner G, Bishop DT, Taylor GR. Exon deletions and duplications in BRCA 1 detected by semiquantitative PCR. <span><span class="ref-journal">Genet Test. </span>2000;<span class="ref-vol">4</span>:49–54.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10794361" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10794361</span></a>]</div></li><li><div class="bk_ref" id="references.r237">Romieu I, et al. Oral contraceptives and breast cancer: review and meta-analysis. <span><span class="ref-journal">Cancer. </span>1990;<span class="ref-vol">66</span>:2253–63.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/2147122" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 2147122</span></a>]</div></li><li><div class="bk_ref" id="references.r238">Rozycka M, Collins N, Stratton MR, Wooster R. Rapid detection of DNA sequence variants by conformation-sensitive capillary electrophoresis. <span><span class="ref-journal">Genomics. </span>2000;<span class="ref-vol">70</span>:34–40.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11087659" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11087659</span></a>]</div></li><li><div class="bk_ref" id="references.r239">Rushton L, Jones DR. Oral contraceptive use and breast cancer risk: A meta-analysis of variations with age at diagnosis, parity and total duration of oral contraceptive use. <span><span class="ref-journal">British Journal of Obstetrics and Gynaecology. </span>1992;<span class="ref-vol">99</span>:239–46.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/1534994" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 1534994</span></a>]</div></li><li><div class="bk_ref" id="references.r240">Sachs L, Taube A, Tishelman C. Risk in numbers--difficulties in the transformation of genetic knowledge from research to people--the case of hereditary cancer. <span><span class="ref-journal">Acta Oncologica. </span>2001;<span class="ref-vol">40</span>:445–53.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11504302" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11504302</span></a>]</div></li><li><div class="bk_ref" id="references.r241">Sætersdal A, Dorum A, Heimdal K, Helgerud P, Sager EM, Bohler P, et al. Inherited predisposition to breast carcinoma. Results of first round examination of 537 women at risk. <span><span class="ref-journal">Anticancer Research. </span>1996;<span class="ref-vol">16</span>:1989–92.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/8712731" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 8712731</span></a>]</div></li><li><div class="bk_ref" id="references.r242">Schairer C, Lubin J, Troisi R, et al. Menopausal oestrogen and oestrogen-progestin replacement therapy and breast cancer risk. <span><span class="ref-journal">JAMA. </span>2000;<span class="ref-vol">283</span>:485–491.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10659874" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10659874</span></a>]</div></li><li><div class="bk_ref" id="references.r243">Schapira MM, Nattinger AB, McHorney CA. Frequency or probability? A qualitative study of risk communication formats used in health care. <span><span class="ref-journal">Medical Decision Making. </span>2001;<span class="ref-vol">21</span>(6):459–67. 459–67.</span> Nov–Dec.(59 ref) [<a href="https://pubmed.ncbi.nlm.nih.gov/11760103" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11760103</span></a>]</div></li><li><div class="bk_ref" id="references.r244">Scheuer L, Kauff N, Robson M, Kelly B, Barakat R, Satagopan J, et al. Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. <span><span class="ref-journal">Journal of Clinical Oncology. </span>2002;<span class="ref-vol">20</span>:1260–8.</span> (see comments) [<a href="https://pubmed.ncbi.nlm.nih.gov/11870168" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11870168</span></a>]</div></li><li><div class="bk_ref" id="references.r245">Schlesselman JJ. Net effect of oral contraceptive use on the risk of cancer in women in the United States. <span><span class="ref-journal">Journal of Obstetrics and Gyanecology. </span>1995;<span class="ref-vol">85</span>:793–801.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/7724116" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 7724116</span></a>]</div></li><li><div class="bk_ref" id="references.r246">Schrag D, et al. Decision analysis - effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 and BRCA2 mutations. <span><span class="ref-journal">New England Journal of Medicine. </span>1997;<span class="ref-vol">336</span>:1465–71.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9148160" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 9148160</span></a>]</div></li><li><div class="bk_ref" id="references.r247">Schwartz MD, Benkendorf J, Lerman C, et al. Impact of educational print materials on knowledge, attitudes and interest in BRCA1/BRCA2: testing among Ashkenazi Jewish women. <span><span class="ref-journal">Cancer. </span>2001;<span class="ref-vol">92</span>:932–940.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11550168" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11550168</span></a>]</div></li><li><div class="bk_ref" id="references.r248">Schwartz MD, Rimer BK, Daly M, et al. A randomized trial of breast cancer risk counseling: the impact on self-reported mammography use. <span><span class="ref-journal">American Journal of Public Health. </span>1999;<span class="ref-vol">89</span>:924–6.</span> [<a href="/pmc/articles/PMC1508646/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC1508646</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10358689" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10358689</span></a>]</div></li><li><div class="bk_ref" id="references.r249">Schwartz MD, et al. Distress, personality, and mammography utilization among women with a family history of breast cancer. <span><span class="ref-journal">Health Psychology. </span>1999;<span class="ref-vol">18</span>:327–32.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10431933" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10431933</span></a>]</div></li><li><div class="bk_ref" id="references.r250">Sellers TA, Mink PJ, Cerham JR, Zheng W, Anderson KE, Kushi LH, et al. The role of hormone replacement therapy in the risk for breast cancer and total mortality in women with a family history of breast cancer. <span><span class="ref-journal">Annals of Internal Medicine. </span>1997;<span class="ref-vol">127</span>:973–80.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9412302" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 9412302</span></a>]</div></li><li><div class="bk_ref" id="references.r251">Sevilla C, Moatti JP, Julian-Reynier C, Eisinger F, Stoppa-Lyonnet D, Bressac-de Paillerets B, Sobol H. Testing for BRCA1 mutations: a cost effectiveness analysis. <span><span class="ref-journal">European Journal of Human Genetics. </span>2002;<span class="ref-vol">10</span>:599–606.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12357330" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 12357330</span></a>]</div></li><li><div class="bk_ref" id="references.r252">Shah S, Evans DGR, Blair V, et al. Assessment of relative risk of second primary tumours after ovarian cancer and the usefulness of double primary cases as a source if material for genetic studies with a cancer registry. <span><span class="ref-journal">Cancer. </span>1993;<span class="ref-vol">72</span>:819–827.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/8334636" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 8334636</span></a>]</div></li><li><div class="bk_ref" id="references.r253">Shiloh S, et al. Motivations, perceptions and interpersonal differences associated with interest in genetic testing for breast cancer susceptibility among women at high and average risk. <span><span class="ref-journal">Psychology and Health. </span>1998;<span class="ref-vol">13</span>:1071–86.</span></div></li><li><div class="bk_ref" id="references.r254">Sillero-Arenas M, et al. Menopausal hormone replacement therapy and breast cancer: a meta-analysis. <span><span class="ref-journal">Obstetrics & Gynecology. </span>1992;<span class="ref-vol">79</span>:286–94.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/1530988" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 1530988</span></a>]</div></li><li><div class="bk_ref" id="references.r255">Smith K, West J, Croyle R, Botkin J. Familial context of genetic testing for cancer susceptibility; moderating effect of siblings’ test result on psychological distress one to two weeks after BRCA1 mutation testing. <span><span class="ref-journal">Cancer, Epidemiology, Biomarkers & Prevention. </span>1999;<span class="ref-vol">8</span>:385–392.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10207644" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10207644</span></a>]</div></li><li><div class="bk_ref" id="references.r256">Smith-Warner SA, Spiegelman D, Yaun SS, van den Brandt PA, Folsom AR, Goldbohm RA, et al. Alcohol and breast cancer in women: a pooled analysis of cohort studies. <span><span class="ref-journal">JAMA. </span>1998;<span class="ref-vol">279</span>:535–40.</span> (see comments) [<a href="https://pubmed.ncbi.nlm.nih.gov/9480365" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 9480365</span></a>]</div></li><li><div class="bk_ref" id="references.r257">Stefanek ME, Helzlsouer KJ, Wilcox PM, Houn F. Predictors of and Satisfaction with Bilateral Prophylactic Mastectomy. <span><span class="ref-journal">Preventive Medicine. </span>1995;<span class="ref-vol">24</span>:412–9.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/7479633" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 7479633</span></a>]</div></li><li><div class="bk_ref" id="references.r258">Steinberg J, Goodwin PJ. Alcohol and breast cancer risk - putting the current controversy into perspective. <span><span class="ref-journal">Breast Cancer Research & Treatment. </span>1991;<span class="ref-vol">19</span>:221–31.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/1838016" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 1838016</span></a>]</div></li><li><div class="bk_ref" id="references.r259">Steinberg KK, Thacker SB, Smith SJ, Stroup DF, Zack MM, Flanders WD, et al. A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer. <span><span class="ref-journal">JAMA. </span>1991;<span class="ref-vol">265</span>:1985–90.</span> (see comments) (erratum appears in JAMA 1991 Sep 11;266(10):1362) [<a href="https://pubmed.ncbi.nlm.nih.gov/1826136" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 1826136</span></a>]</div></li><li><div class="bk_ref" id="references.r260">Stoutjesdijk MJ, Boetes C, Jager GJ, Beex L, Bult P, Hendriks JH, et al. Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer.(comment). <span><span class="ref-journal">Journal of the National Cancer Institute. </span>2001;<span class="ref-vol">93</span>:1095–102.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11459871" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11459871</span></a>]</div></li><li><div class="bk_ref" id="references.r261">Stratton JF, Thompson D, Bobrow L, et al. The genetic epidemiology of early-onset epithelial ovarian cancer: a population-based study. <span><span class="ref-journal">Am J Hum Genet. </span>1999;<span class="ref-vol">65</span>:1725–32.</span> [<a href="/pmc/articles/PMC1288384/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC1288384</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10577927" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10577927</span></a>]</div></li><li><div class="bk_ref" id="references.r262">Stratton JF, Pharoah P, Smith SK, Easton D, Ponder B. A systematic review and meta-analysis of family history and risk of ovarian cancer. <span><span class="ref-journal">British Journal of Obstetrics and Gynaecology. </span>1998;<span class="ref-vol">105</span>:493–9.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9637117" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 9637117</span></a>]</div></li><li><div class="bk_ref" id="references.r263">Struewing JP, Lerman C, Kase RG, Giambarresi TR, Tucker MA. Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families. <span><span class="ref-journal">Cancer Epidemiology, Biomarkers & Prevention. </span>1995;<span class="ref-vol">4</span>:169–73.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/7742725" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 7742725</span></a>]</div></li><li><div class="bk_ref" id="references.r264">Struewing JP, Watson P, Easton DF, Ponder BA, Lynch HT, Tucker MA. Prophylactic oophorectomy in inherited breast/ovarian cancer families. <span><span class="ref-journal">Journal of the National Cancer Institute Monographs. </span>1995:33–5.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/8573450" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 8573450</span></a>]</div></li><li><div class="bk_ref" id="references.r265">Sutcliffe S, Pharoah PDP, Easton DF, et al.
|
||
UKCCCR Familial Ovarian Cancer Study Group. Ovarian and breast cancer risks to women in families with two or more cases of ovarian cancer. <span><span class="ref-journal">Int J Cancer. </span>2000;<span class="ref-vol">87</span>:110–117.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10861460" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10861460</span></a>]</div></li><li><div class="bk_ref" id="references.r266">Tabar L, Yen MF, Vitak B, et al. Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. <span><span class="ref-journal">Lancet. </span>2003;<span class="ref-vol">361</span>:1405–10.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12727392" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 12727392</span></a>]</div></li><li><div class="bk_ref" id="references.r267">Taplin S, et al. Revisions in the risk-based breast cancer screening program at Group Health Cooperative. <span><span class="ref-journal">Cancer. </span>1990;<span class="ref-vol">66</span>:812–18.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/2386908" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 2386908</span></a>]</div></li><li><div class="bk_ref" id="references.r268">Tengs T, Winer EP, Paddock S, Aguilar-Chavez O, Berry DA. Testing for the BRCA1 and BRCA2 breast-ovarian cancer susceptibility genes: A decision analysis. <span><span class="ref-journal">Medical Decision Making. </span>1998;<span class="ref-vol">18</span>(4):365–75.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10372578" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10372578</span></a>]</div></li><li><div class="bk_ref" id="references.r269">Tengs TO, Berry DA. The cost effectiveness of testing for the BRCA1 and BRCA2 breast-ovarian cancer susceptibility genes. <span><span class="ref-journal">Disease Management and Clinical Outcome. </span>2000;<span class="ref-vol">1</span>:15–24.</span></div></li><li><div class="bk_ref" id="references.r270">Tercyak K, Lerman C, Peshkin B, et al. Effects of coping style and BRCA1 and BRCA2 test results on anxiety among women participating in genetic counselling and testing for breast and ovarian cancer risk. <span><span class="ref-journal">Health Psychology. </span>2001;<span class="ref-vol">20</span>:217–22.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11403219" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11403219</span></a>]</div></li><li><div class="bk_ref" id="references.r271">Terry PD, Miller AB, Rohan TE. Cigarette smoking and breast cancer risk: along latency period? <span><span class="ref-journal">International Journal of Cancer. </span>2002;<span class="ref-vol">100</span>:723–8.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12209614" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 12209614</span></a>]</div></li><li><div class="bk_ref" id="references.r272">Theis B, Boyd N, Lockwood G, Tritchler D. Accuracy of family cancer history in breast cancer patients. <span><span class="ref-journal">European Journal of Cancer Prevention. </span>1994;<span class="ref-vol">3</span>:321–7.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/7950886" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 7950886</span></a>]</div></li><li><div class="bk_ref" id="references.r273">Tilanus-Linthorst MM, Bartels CC, Obdeijn AI, Oudkerk M. Earlier detection of breast cancer by surveillance of women at familial risk. <span><span class="ref-journal">European Journal of Cancer. </span>2000;<span class="ref-vol">36</span>:514–9.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10717529" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10717529</span></a>]</div></li><li><div class="bk_ref" id="references.r274">Tilanus-Linthorst MM, Obdeijn IM, Bartels KC, de Koning HJ, Oudkerk M. First experiences in screening women at high risk for breast cancer with MR imaging. <span><span class="ref-journal">Breast Cancer Research & Treatment. </span>2000;<span class="ref-vol">63</span>:53–60.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11079159" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11079159</span></a>]</div></li><li><div class="bk_ref" id="references.r275">Tiller K, Meiser B, Butow P, et al. Psychological impact of prophylactic oophorectomy in women at increased risk of developing ovarian cancer. <span><span class="ref-journal">Gynecol Oncol. </span>2002;<span class="ref-vol">86</span>(2):212–9.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12144830" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 12144830</span></a>]</div></li><li><div class="bk_ref" id="references.r276">Tischkowitz M, Wheeler D, France E, Chapman C, Lucassen A, Sampson J, et al. A comparison of methods currently used in clinical practice to estimate familial breast cancer risks. <span><span class="ref-journal">Annals of Oncology. </span>2000;<span class="ref-vol">11</span>:451–4.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10847465" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10847465</span></a>]</div></li><li><div class="bk_ref" id="references.r277">Unger MA, Nathanson KL, Calzone K, Antin-Ozerkis D, Shih HA, Martin AM, et al. Screening for genomic rearrangements in families with breat and ovarian cancer identifies BRCA 1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing. <span><span class="ref-journal">Am J Hum Genet. </span>2003;<span class="ref-vol">67</span>:841–50.</span> [<a href="/pmc/articles/PMC1287889/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC1287889</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10978226" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10978226</span></a>]</div></li><li><div class="bk_ref" id="references.r278">Ursin G, Tseng CC, Paganini-Hill A, Enger S, Wan PC, Formenti S, et al. Does menopausal hormone replacement therapy interact with known factors to increase risk of breast cancer? <span><span class="ref-journal">Journal of Clinical Oncology. </span>2002;<span class="ref-vol">20</span>:699–706.</span> (see comments) [<a href="https://pubmed.ncbi.nlm.nih.gov/11821451" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11821451</span></a>]</div></li><li><div class="bk_ref" id="references.r279">Vachon CM, et al. Investigation of an interaction of alcohol intake and family history on breast cancer risk in Minnesota breast cancer family study. <span><span class="ref-journal">Cancer. </span>2001;<span class="ref-vol">92</span>:240–8.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11466675" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11466675</span></a>]</div></li><li><div class="bk_ref" id="references.r280">Van Hoften C, Burger H, Peeters PHM, Grobbee DE, Van Noord PAH, Leufkens HGM. Long-term oral contraceptive use increases breast cancer risk in women over 55 years of age: The DOM cohort. <span><span class="ref-journal">Int J Cancer. </span>2000;<span class="ref-vol">87</span>:591–4.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10918202" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10918202</span></a>]</div></li><li><div class="bk_ref" id="references.r281">Van Roosmale MS, et al. Decision analysis of prophylactic surgery or screening for BRCA1 mutation carriers: a more prominent role for oophorectomy. <span><span class="ref-journal">Journal of Clinical Oncology. </span>2002;<span class="ref-vol">20</span>:2092–100.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11956270" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11956270</span></a>]</div></li><li><div class="bk_ref" id="references.r282">van Zuuren FJ, van Schie ECM, van Baaren NK. Uncertainty in the information provided during genetic counselling. <span><span class="ref-journal">Patient Education and Counselling. </span>1997;<span class="ref-vol">32</span>:129–139.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9355580" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 9355580</span></a>]</div></li><li><div class="bk_ref" id="references.r283">Veronesi U, Maisonneuve P, Costa A, Sacchini V, Maltoni C, Robertson C, et al. Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women... including commentary by Pritchard KI. <span><span class="ref-journal">Lancet. </span>1998 1998 1980 Jul 11;<span class="ref-vol">352</span><span class="ref-vol">352</span>(9122):93–7. 80–1, 93–7.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9672273" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 9672273</span></a>]</div></li><li><div class="bk_ref" id="references.r284">Veronesi U, Maisonneuve P, Sacchini V, Rotmensz N, Boyle P. Tamoxifen for breast cancer among hysterectomised women. <span><span class="ref-journal">Lancet. </span>2002;<span class="ref-vol">359</span>:1122–4.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11943263" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11943263</span></a>]</div></li><li><div class="bk_ref" id="references.r285">Wagner T, Stoppa-Lyonnet D, Fleischmann E, Muir D, Pages S, Sandberg T, et al. Denaturing high-performance liquid chromatography detects relability BRCA 1 and BRCA 2 mutations. <span><span class="ref-journal">Genomics. </span>1999;<span class="ref-vol">62</span>:369–76.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10644434" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10644434</span></a>]</div></li><li><div class="bk_ref" id="references.r286">Wagner TM, Moslinger R, Langbauer G, Ahner R, Fleischmann E, Auterith A, et al. Attitude towards prophylactic surgery and effects of genetic counselling in families with BRCA mutations. Austrian Hereditary Breast and Ovarian Cancer Group. <span><span class="ref-journal">British Journal of Cancer. </span>2000;<span class="ref-vol">82</span>:1249–53.</span> [<a href="/pmc/articles/PMC2374490/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC2374490</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10755396" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10755396</span></a>]</div></li><li><div class="bk_ref" id="references.r287">Warner E, Plewes DB, Shumak RS, Catzavelos GC, Di Prospero LS, Yaffe MJ, et al. Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer.(comment). <span><span class="ref-journal">Journal of Clinical Oncology. </span>2001;<span class="ref-vol">19</span>:3524–31.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11481359" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11481359</span></a>]</div></li><li><div class="bk_ref" id="references.r288">Watson E, Clements A, Lucassen P, et al. Education improves general practitioner (GP) management of familial breast/ovarian cancer: findings from a cluster randomised controlled trial (Letter). <span><span class="ref-journal">Journal of Medical Genetics. </span>2002;<span class="ref-vol">39</span>:779–781.</span> [<a href="/pmc/articles/PMC1734993/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC1734993</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12362040" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 12362040</span></a>]</div></li><li><div class="bk_ref" id="references.r289">Watson E, Clements A, Yudkin P, et al. Evaluation of the impact of two educational interventions on GP management of familial breast/ovarian cancer cases: a cluster randomised controlled trial. <span><span class="ref-journal">British Journal of General Practice. </span>2001;<span class="ref-vol">51</span>:817–821.</span> [<a href="/pmc/articles/PMC1314127/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC1314127</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11677705" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11677705</span></a>]</div></li><li><div class="bk_ref" id="references.r290">Watson M, et al. Psychological impact of testing (by linkage) for the BRCA1 breast cancer gene: an investigation of two families in the research setting. <span><span class="ref-journal">Psycho-Oncology. </span>1996;<span class="ref-vol">5</span>:233–9.</span></div></li><li><div class="bk_ref" id="references.r291">Watson M, Duvivier V, Wade Walsh M, Ashley S, Davidson J, Papaikonomou M, Murday V, Sacks N, Eeles R. Family history of breast cancer: what do women understand and recall about their risk? <span><span class="ref-journal">Journal of Medical Genetics. </span>1998;<span class="ref-vol">35</span>:731–738.</span> [<a href="/pmc/articles/PMC1051425/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC1051425</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9733031" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 9733031</span></a>]</div></li><li><div class="bk_ref" id="references.r292">Watson M, Lloyd S, Davidson J, Meyer L, Eeles R, Ebbs S, Murday V. The impact of genetic counselling on risk perception and mental health in women with a family history of breast cancer. <span><span class="ref-journal">British Journal of Cancer. </span>1999;<span class="ref-vol">79</span>:868–874.</span> [<a href="/pmc/articles/PMC2362694/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC2362694</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10070883" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10070883</span></a>]</div></li><li><div class="bk_ref" id="references.r293">Werness BA, Ramus SJ, Whittemore AS, et al. Histopathology of familial ovarian tumors in women from families with and without germline BRCA1 mutations. <span><span class="ref-journal">Hum Pathol. </span>2000;<span class="ref-vol">31</span>:1420–4.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11112219" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11112219</span></a>]</div></li><li><div class="bk_ref" id="references.r294">Willemsen HW, Kaas R, Peterse JH, Rutgers EJT. Breast carcinoma in residual breast tissue after prophylactic bilateral subcutaneous mastectomy. <span><span class="ref-journal">European Journal of Surgical Oncology. </span>1998;<span class="ref-vol">24</span>:331–2.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9725003" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 9725003</span></a>]</div></li><li><div class="bk_ref" id="references.r295">Winter PR, Wiesner GL, Finnegan J, Bartels D, LeRoy B, Chen PL, et al. Notification of a family history of breast cancer: issues of privacy and confidentiality. <span><span class="ref-journal">American Journal of Medical Genetics. </span>1996;<span class="ref-vol">66</span>:1–6.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/8957501" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 8957501</span></a>]</div></li><li><div class="bk_ref" id="references.r296">Ziegler LD, Kroll SS. Primary Breast-Cancer After Prophylactic Mastectomy. <span><span class="ref-journal">American Journal of Clinical Oncology-Cancer Clinical Trials. </span>1991;<span class="ref-vol">14</span>:451–4.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/1951182" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 1951182</span></a>]</div></li></ul><div id="bk_toc_contnr"></div></div></div>
|
||
<div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 2004, School of Health and Related Research (ScHARR), University of Sheffield.</div><div class="small"><span class="label">Bookshelf ID: NBK65453</span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/nicecg14/">Contents</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/nicecg14/glossary.gl1/" title="Previous page in this title">< Prev</a><a class="active page_link next" href="/books/n/nicecg14/appendixes.appgroup1/" title="Next page in this title">Next ></a></div></div></div></div>
|
||
|
||
</div>
|
||
|
||
<!-- Custom content below content -->
|
||
<div class="col4">
|
||
|
||
</div>
|
||
|
||
|
||
<!-- Book content -->
|
||
|
||
<!-- Custom contetnt below bottom nav -->
|
||
<div class="col5">
|
||
|
||
</div>
|
||
</div>
|
||
|
||
<div id="rightcolumn" class="four_col col last">
|
||
<!-- Custom content above discovery portlets -->
|
||
<div class="col6">
|
||
<div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK65453&db=books">Share</a></div>
|
||
|
||
</div>
|
||
<div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK65453/?report=reader">PubReader</a></li><li><a href="/books/NBK65453/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK65453" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK65453" style="display:none" title="Cite this Page"><div class="bk_tt">School of Health and Related Research (ScHARR), University of Sheffield. Clinical Guidelines for the Classification and Care of Women at Risk of Familial Breast Cancer in Primary, Secondary and Tertiary Care [Internet]. Sheffield (UK): University of Sheffield; 2004 May. (NICE Clinical Guidelines, No. 14.) 12. References.<span class="bk_cite_avail"></span></div></div></li><li><a href="/books/n/nicecg14/pdf/">PDF version of this title</a> (7.0M)</li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Other titles in this collection</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/nicecollect/">National Institute for Health and Clinical Excellence: Guidance
|
||
</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related NICE guidance and evidence</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/nicecg41/">NICE Clinical Guideline 41: Familial Breast Cancer: The Classification and Care of Women at Risk of Familial Breast Cancer in Primary, Secondary and Tertiary Care: Update</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=67d7a31167c23b31e0b05620">12. References - Clinical Guidelines for the Classification and Care of Women at...</a><div class="ralinkpop offscreen_noflow">12. References - Clinical Guidelines for the Classification and Care of Women at Risk of Familial Breast Cancer in Primary, Secondary and Tertiary Care<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&linkpos=2" href="/portal/utils/pageresolver.fcgi?recordid=67d7a310cde49f3df7e48f4a">11. Selected glossary - Clinical Guidelines for the Classification and Care of W...</a><div class="ralinkpop offscreen_noflow">11. Selected glossary - Clinical Guidelines for the Classification and Care of Women at Risk of Familial Breast Cancer in Primary, Secondary and Tertiary Care<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&linkpos=3" href="/portal/utils/pageresolver.fcgi?recordid=67d7a30f84f3725e592b42ed">Research issues - Clinical Guidelines for the Classification and Care of Women a...</a><div class="ralinkpop offscreen_noflow">Research issues - Clinical Guidelines for the Classification and Care of Women at Risk of Familial Breast Cancer in Primary, Secondary and Tertiary Care<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&linkpos=4" href="/portal/utils/pageresolver.fcgi?recordid=67d7a30e84f3725e592b3e6e">Audit criteria - Clinical Guidelines for the Classification and Care of Women at...</a><div class="ralinkpop offscreen_noflow">Audit criteria - Clinical Guidelines for the Classification and Care of Women at Risk of Familial Breast Cancer in Primary, Secondary and Tertiary Care<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&linkpos=5" href="/portal/utils/pageresolver.fcgi?recordid=67d7a30dcde49f3df7e48136">Risk factors - Clinical Guidelines for the Classification and Care of Women at R...</a><div class="ralinkpop offscreen_noflow">Risk factors - Clinical Guidelines for the Classification and Care of Women at Risk of Familial Breast Cancer in Primary, Secondary and Tertiary Care<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
|
||
|
||
<!-- Custom content below discovery portlets -->
|
||
<div class="col7">
|
||
|
||
</div>
|
||
</div>
|
||
</div>
|
||
|
||
<!-- Custom content after all -->
|
||
<div class="col8">
|
||
|
||
</div>
|
||
<div class="col9">
|
||
|
||
</div>
|
||
|
||
<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
|
||
<script type="text/javascript">
|
||
(function($){
|
||
$('.skiplink').each(function(i, item){
|
||
var href = $($(item).attr('href'));
|
||
href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
|
||
$(item).on('click', function(event){
|
||
event.preventDefault();
|
||
$.scrollTo(href, 0, {
|
||
onAfter: function(){
|
||
href.focus();
|
||
}
|
||
});
|
||
});
|
||
});
|
||
})(jQuery);
|
||
</script>
|
||
</div>
|
||
<div class="bottom">
|
||
|
||
<div id="NCBIFooter_dynamic">
|
||
<!--<component id="Breadcrumbs" label="breadcrumbs"/>
|
||
<component id="Breadcrumbs" label="helpdesk"/>-->
|
||
|
||
</div>
|
||
|
||
<div class="footer" id="footer">
|
||
<section class="icon-section">
|
||
<div id="icon-section-header" class="icon-section_header">Follow NCBI</div>
|
||
<div class="grid-container container">
|
||
<div class="icon-section_container">
|
||
<a class="footer-icon" id="footer_twitter" href="https://twitter.com/ncbi" aria-label="Twitter"><svg xmlns="http://www.w3.org/2000/svg" data-name="Layer 1" viewBox="0 0 300 300">
|
||
<defs>
|
||
<style>
|
||
.cls-11 {
|
||
fill: #737373;
|
||
}
|
||
</style>
|
||
</defs>
|
||
<title>Twitter</title>
|
||
<path class="cls-11" d="M250.11,105.48c-7,3.14-13,3.25-19.27.14,8.12-4.86,8.49-8.27,11.43-17.46a78.8,78.8,0,0,1-25,9.55,39.35,39.35,0,0,0-67,35.85,111.6,111.6,0,0,1-81-41.08A39.37,39.37,0,0,0,81.47,145a39.08,39.08,0,0,1-17.8-4.92c0,.17,0,.33,0,.5a39.32,39.32,0,0,0,31.53,38.54,39.26,39.26,0,0,1-17.75.68,39.37,39.37,0,0,0,36.72,27.3A79.07,79.07,0,0,1,56,223.34,111.31,111.31,0,0,0,116.22,241c72.3,0,111.83-59.9,111.83-111.84,0-1.71,0-3.4-.1-5.09C235.62,118.54,244.84,113.37,250.11,105.48Z">
|
||
</path>
|
||
</svg></a>
|
||
<a class="footer-icon" id="footer_facebook" href="https://www.facebook.com/ncbi.nlm" aria-label="Facebook"><svg xmlns="http://www.w3.org/2000/svg" data-name="Layer 1" viewBox="0 0 300 300">
|
||
<title>Facebook</title>
|
||
<path class="cls-11" d="M210.5,115.12H171.74V97.82c0-8.14,5.39-10,9.19-10h27.14V52l-39.32-.12c-35.66,0-42.42,26.68-42.42,43.77v19.48H99.09v36.32h27.24v109h45.41v-109h35Z">
|
||
</path>
|
||
</svg></a>
|
||
<a class="footer-icon" id="footer_linkedin" href="https://www.linkedin.com/company/ncbinlm" aria-label="LinkedIn"><svg xmlns="http://www.w3.org/2000/svg" data-name="Layer 1" viewBox="0 0 300 300">
|
||
<title>LinkedIn</title>
|
||
<path class="cls-11" d="M101.64,243.37H57.79v-114h43.85Zm-22-131.54h-.26c-13.25,0-21.82-10.36-21.82-21.76,0-11.65,8.84-21.15,22.33-21.15S101.7,78.72,102,90.38C102,101.77,93.4,111.83,79.63,111.83Zm100.93,52.61A17.54,17.54,0,0,0,163,182v61.39H119.18s.51-105.23,0-114H163v13a54.33,54.33,0,0,1,34.54-12.66c26,0,44.39,18.8,44.39,55.29v58.35H198.1V182A17.54,17.54,0,0,0,180.56,164.44Z">
|
||
</path>
|
||
</svg></a>
|
||
<a class="footer-icon" id="footer_github" href="https://github.com/ncbi" aria-label="GitHub"><svg xmlns="http://www.w3.org/2000/svg" data-name="Layer 1" viewBox="0 0 300 300">
|
||
<defs>
|
||
<style>
|
||
.cls-11,
|
||
.cls-12 {
|
||
fill: #737373;
|
||
}
|
||
|
||
.cls-11 {
|
||
fill-rule: evenodd;
|
||
}
|
||
</style>
|
||
</defs>
|
||
<title>GitHub</title>
|
||
<path class="cls-11" d="M151.36,47.28a105.76,105.76,0,0,0-33.43,206.1c5.28,1,7.22-2.3,7.22-5.09,0-2.52-.09-10.85-.14-19.69-29.42,6.4-35.63-12.48-35.63-12.48-4.81-12.22-11.74-15.47-11.74-15.47-9.59-6.56.73-6.43.73-6.43,10.61.75,16.21,10.9,16.21,10.9,9.43,16.17,24.73,11.49,30.77,8.79,1-6.83,3.69-11.5,6.71-14.14C108.57,197.1,83.88,188,83.88,147.51a40.92,40.92,0,0,1,10.9-28.39c-1.1-2.66-4.72-13.42,1-28,0,0,8.88-2.84,29.09,10.84a100.26,100.26,0,0,1,53,0C198,88.3,206.9,91.14,206.9,91.14c5.76,14.56,2.14,25.32,1,28a40.87,40.87,0,0,1,10.89,28.39c0,40.62-24.74,49.56-48.29,52.18,3.79,3.28,7.17,9.71,7.17,19.58,0,14.15-.12,25.54-.12,29,0,2.82,1.9,6.11,7.26,5.07A105.76,105.76,0,0,0,151.36,47.28Z">
|
||
</path>
|
||
<path class="cls-12" d="M85.66,199.12c-.23.52-1.06.68-1.81.32s-1.2-1.06-.95-1.59,1.06-.69,1.82-.33,1.21,1.07.94,1.6Zm-1.3-1">
|
||
</path>
|
||
<path class="cls-12" d="M90,203.89c-.51.47-1.49.25-2.16-.49a1.61,1.61,0,0,1-.31-2.19c.52-.47,1.47-.25,2.17.49s.82,1.72.3,2.19Zm-1-1.08">
|
||
</path>
|
||
<path class="cls-12" d="M94.12,210c-.65.46-1.71,0-2.37-.91s-.64-2.07,0-2.52,1.7,0,2.36.89.65,2.08,0,2.54Zm0,0"></path>
|
||
<path class="cls-12" d="M99.83,215.87c-.58.64-1.82.47-2.72-.41s-1.18-2.06-.6-2.7,1.83-.46,2.74.41,1.2,2.07.58,2.7Zm0,0">
|
||
</path>
|
||
<path class="cls-12" d="M107.71,219.29c-.26.82-1.45,1.2-2.64.85s-2-1.34-1.74-2.17,1.44-1.23,2.65-.85,2,1.32,1.73,2.17Zm0,0">
|
||
</path>
|
||
<path class="cls-12" d="M116.36,219.92c0,.87-1,1.59-2.24,1.61s-2.29-.68-2.3-1.54,1-1.59,2.26-1.61,2.28.67,2.28,1.54Zm0,0">
|
||
</path>
|
||
<path class="cls-12" d="M124.42,218.55c.15.85-.73,1.72-2,1.95s-2.37-.3-2.52-1.14.73-1.75,2-2,2.37.29,2.53,1.16Zm0,0"></path>
|
||
</svg></a>
|
||
<a class="footer-icon" id="footer_blog" href="https://ncbiinsights.ncbi.nlm.nih.gov/" aria-label="Blog">
|
||
<svg xmlns="http://www.w3.org/2000/svg" id="Layer_1" data-name="Layer 1" viewBox="0 0 40 40">
|
||
<defs><style>.cls-1{fill:#737373;}</style></defs>
|
||
<title>NCBI Insights Blog</title>
|
||
<path class="cls-1" d="M14,30a4,4,0,1,1-4-4,4,4,0,0,1,4,4Zm11,3A19,19,0,0,0,7.05,15a1,1,0,0,0-1,1v3a1,1,0,0,0,.93,1A14,14,0,0,1,20,33.07,1,1,0,0,0,21,34h3a1,1,0,0,0,1-1Zm9,0A28,28,0,0,0,7,6,1,1,0,0,0,6,7v3a1,1,0,0,0,1,1A23,23,0,0,1,29,33a1,1,0,0,0,1,1h3A1,1,0,0,0,34,33Z"></path>
|
||
</svg>
|
||
</a>
|
||
</div>
|
||
</div>
|
||
</section>
|
||
|
||
<section class="container-fluid bg-primary">
|
||
<div class="container pt-5">
|
||
<div class="row mt-3">
|
||
<div class="col-lg-3 col-12">
|
||
<p><a class="text-white" href="https://www.nlm.nih.gov/socialmedia/index.html">Connect with NLM</a></p>
|
||
<ul class="list-inline social_media">
|
||
<li class="list-inline-item"><a href="https://twitter.com/NLM_NIH" aria-label="Twitter" target="_blank" rel="noopener noreferrer"><svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" version="1.1" x="0px" y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
|
||
<style type="text/css">
|
||
.st20 {
|
||
fill: #FFFFFF;
|
||
}
|
||
|
||
.st30 {
|
||
fill: none;
|
||
stroke: #FFFFFF;
|
||
stroke-width: 8;
|
||
stroke-miterlimit: 10;
|
||
}
|
||
</style>
|
||
<title>Twitter</title>
|
||
<g>
|
||
<g>
|
||
<g>
|
||
<path class="st20" d="M192.9,88.1c-5,2.2-9.2,2.3-13.6,0.1c5.7-3.4,6-5.8,8.1-12.3c-5.4,3.2-11.4,5.5-17.6,6.7 c-10.5-11.2-28.1-11.7-39.2-1.2c-7.2,6.8-10.2,16.9-8,26.5c-22.3-1.1-43.1-11.7-57.2-29C58,91.6,61.8,107.9,74,116 c-4.4-0.1-8.7-1.3-12.6-3.4c0,0.1,0,0.2,0,0.4c0,13.2,9.3,24.6,22.3,27.2c-4.1,1.1-8.4,1.3-12.5,0.5c3.6,11.3,14,19,25.9,19.3 c-11.6,9.1-26.4,13.2-41.1,11.5c12.7,8.1,27.4,12.5,42.5,12.5c51,0,78.9-42.2,78.9-78.9c0-1.2,0-2.4-0.1-3.6 C182.7,97.4,189.2,93.7,192.9,88.1z"></path>
|
||
</g>
|
||
</g>
|
||
<circle class="st30" cx="124.4" cy="128.8" r="108.2"></circle>
|
||
</g>
|
||
</svg></a></li>
|
||
<li class="list-inline-item"><a href="https://www.facebook.com/nationallibraryofmedicine" aria-label="Facebook" rel="noopener noreferrer" target="_blank">
|
||
<svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" version="1.1" x="0px" y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
|
||
<style type="text/css">
|
||
.st10 {
|
||
fill: #FFFFFF;
|
||
}
|
||
|
||
.st110 {
|
||
fill: none;
|
||
stroke: #FFFFFF;
|
||
stroke-width: 8;
|
||
stroke-miterlimit: 10;
|
||
}
|
||
</style>
|
||
<title>Facebook</title>
|
||
<g>
|
||
<g>
|
||
<path class="st10" d="M159,99.1h-24V88.4c0-5,3.3-6.2,5.7-6.2h16.8V60l-24.4-0.1c-22.1,0-26.2,16.5-26.2,27.1v12.1H90v22.5h16.9 v67.5H135v-67.5h21.7L159,99.1z"></path>
|
||
</g>
|
||
</g>
|
||
<circle class="st110" cx="123.6" cy="123.2" r="108.2"></circle>
|
||
</svg>
|
||
</a></li>
|
||
<li class="list-inline-item"><a href="https://www.youtube.com/user/NLMNIH" aria-label="Youtube" target="_blank" rel="noopener noreferrer"><svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" version="1.1" x="0px" y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
|
||
<title>Youtube</title>
|
||
<style type="text/css">
|
||
.st4 {
|
||
fill: none;
|
||
stroke: #FFFFFF;
|
||
stroke-width: 8;
|
||
stroke-miterlimit: 10;
|
||
}
|
||
|
||
.st5 {
|
||
fill: #FFFFFF;
|
||
}
|
||
</style>
|
||
<circle class="st4" cx="124.2" cy="123.4" r="108.2"></circle>
|
||
<g transform="translate(0,-952.36218)">
|
||
<path class="st5" d="M88.4,1037.4c-10.4,0-18.7,8.3-18.7,18.7v40.1c0,10.4,8.3,18.7,18.7,18.7h72.1c10.4,0,18.7-8.3,18.7-18.7 v-40.1c0-10.4-8.3-18.7-18.7-18.7H88.4z M115.2,1058.8l29.4,17.4l-29.4,17.4V1058.8z"></path>
|
||
</g>
|
||
</svg></a></li>
|
||
</ul>
|
||
</div>
|
||
<div class="col-lg-3 col-12">
|
||
<p class="address_footer text-white">National Library of Medicine<br />
|
||
<a href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/@38.9959508,-77.101021,17z/data=!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb:0x19156f88b27635b8!8m2!3d38.9959508!4d-77.0988323" class="text-white" target="_blank" rel="noopener noreferrer">8600 Rockville Pike<br />
|
||
Bethesda, MD 20894</a></p>
|
||
</div>
|
||
<div class="col-lg-3 col-12 centered-lg">
|
||
<p><a href="https://www.nlm.nih.gov/web_policies.html" class="text-white">Web Policies</a><br />
|
||
<a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="text-white">FOIA</a><br />
|
||
<a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="text-white" id="vdp">HHS Vulnerability Disclosure</a></p>
|
||
</div>
|
||
<div class="col-lg-3 col-12 centered-lg">
|
||
<p><a class="supportLink text-white" href="https://support.nlm.nih.gov/">Help</a><br />
|
||
<a href="https://www.nlm.nih.gov/accessibility.html" class="text-white">Accessibility</a><br />
|
||
<a href="https://www.nlm.nih.gov/careers/careers.html" class="text-white">Careers</a></p>
|
||
</div>
|
||
</div>
|
||
<div class="row">
|
||
<div class="col-lg-12 centered-lg">
|
||
<nav class="bottom-links">
|
||
<ul class="mt-3">
|
||
<li>
|
||
<a class="text-white" href="//www.nlm.nih.gov/">NLM</a>
|
||
</li>
|
||
<li>
|
||
<a class="text-white" href="https://www.nih.gov/">NIH</a>
|
||
</li>
|
||
<li>
|
||
<a class="text-white" href="https://www.hhs.gov/">HHS</a>
|
||
</li>
|
||
<li>
|
||
<a class="text-white" href="https://www.usa.gov/">USA.gov</a>
|
||
</li>
|
||
</ul>
|
||
</nav>
|
||
</div>
|
||
</div>
|
||
</div>
|
||
</section>
|
||
<script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>
|
||
<script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
|
||
</div>
|
||
</div>
|
||
</div>
|
||
<!--/.page-->
|
||
</div>
|
||
<!--/.wrap-->
|
||
</div><!-- /.twelve_col -->
|
||
</div>
|
||
<!-- /.grid -->
|
||
|
||
<span class="PAFAppResources"></span>
|
||
|
||
<!-- BESelector tab -->
|
||
|
||
|
||
|
||
<noscript><img alt="statistics" src="/stat?jsdisabled=true&ncbi_db=books&ncbi_pdid=book-part&ncbi_acc=NBK65453&ncbi_domain=nicecg14&ncbi_report=record&ncbi_type=fulltext&ncbi_objectid=&ncbi_pcid=/NBK65453/&ncbi_pagename=12. References - Clinical Guidelines for the Classification and Care of Women at Risk of Familial Breast Cancer in Primary, Secondary and Tertiary Care - NCBI Bookshelf&ncbi_bookparttype=ref-list&ncbi_app=bookshelf" /></noscript>
|
||
|
||
|
||
<!-- usually for JS scripts at page bottom -->
|
||
<!--<component id="PageFixtures" label="styles"></component>-->
|
||
|
||
|
||
<!-- CE8B5AF87C7FFCB1_0191SID /projects/books/PBooks@9.11 portal104 v4.1.r689238 Tue, Oct 22 2024 16:10:51 -->
|
||
<span id="portal-csrf-token" style="display:none" data-token="CE8B5AF87C7FFCB1_0191SID"></span>
|
||
|
||
<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4209313/4212053/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
|
||
</html> |